"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,KR,A,KR 20120008208 A,012-186-078-040-429,2012-01-30,2012,KR 20100068936 A,2010-07-16,KR 20100068936 A,2010-07-16,ELECTROCHEMICAL GAS SENSOR AND METHOD FOR FABRICATING THE SAME,"PURPOSE: An electrochemical gas sensor and a manufacturing method thereof are provided to maintain the uniform properties of the sensor even if the content of metal catalysts is reduced. CONSTITUTION: An electrochemical gas sensor comprises a sensing electrode(100), an opposite electrode(200), and an electrolyte(300). The sensing electrode comprises a porous substrate and a carbon compound-metal nano particle layer. The carbon compound-metal nano particle layer is located at the top of the porous substrate. The opposite electrode corresponds to the sensing electrode. The electrolyte is inserted between the sensing and opposite electrodes.",IUCF HYU,KIM YONG SHIN;;LA DUC DUONG,,https://lens.org/012-186-078-040-429,Patent Application,no,0,7,1,1,0,G01N27/4071;;G01N27/4075;;G01N27/417,G01N27/417,,0,0,,,,DISCONTINUED
2,US,A1,US 2019/0281928 A1,008-930-224-407-582,2019-09-19,2019,US 201916352750 A,2019-03-13,US 201916352750 A;;US 201862761173 P,2018-03-14,SHOE ACCESSORY SYSTEM,"A shoe accessory system and methods can include: an accessory connector having a male accessory mount and a female accessory mount: the male accessory mount including a base, a protrusion mounted above the base, an outwardly protruding lip extending from the protrusion, the outwardly protruding lip having a slope extending down toward an abutment, and the female accessory mount having inwardly extending flanges, the inwardly extending flanges extend in toward a center of the female accessory mount, the inwardly extending flanges spaced apart allowing the protrusion to fit therebetween; a shoe affixed to the male accessory mount; and an accessory affixable to the female accessory mount for allowing the accessory to be placed over the male accessory mount, pressed down, and twisted to lock the accessory onto the shoe.",NGUYEN THUY DUONG;;NGUYEN DUC ANTOINE,NGUYEN THUY DUONG;;NGUYEN DUC ANTOINE,THRIVE INTERNATIONAL INC (2021-06-30);;BAUBLES AND SOLES INC (2021-09-07),https://lens.org/008-930-224-407-582,Patent Application,yes,0,1,2,2,0,A43B3/30;;A43B23/24;;A43B3/30;;A43B23/24;;B29C45/14;;B29L2031/50,A43B23/24;;A43B3/30,,0,0,,,,ACTIVE
3,US,A1,US 2017/0172715 A1,184-976-753-629-207,2017-06-22,2017,US 201615374688 A,2016-12-09,US 201615374688 A;;US 201514835498 A;;US 201662388745 P;;US 201662493805 P;;US 201462070388 P;;US 201462124302 P,2014-08-25,FLOSS DISPENSERS,"Floss cartridges are described. In one embodiment, a floss cartridge may comprise a cartridge chassis configured to hold floss, and a pair of rollers coupled to the cartridge chassis. The rollers may contact each other at a pinch point. The rollers may be configured to feed the floss through the pinch point at a feed angle. Methods of using a floss dispenser are also described. In one embodiment, the method may comprise coupling a floss cartridge to a housing. The floss cartridge may be configured to hold floss. The floss cartridge may have a pair of rollers contacting each other at a pinch point. The method may also comprise driving a pair of rollers to feed the floss from the pinch point at a feed angle.",FLOSSTIME INC,DUONG DUC;;FARIA GREGORIO;;EVANS MICHAEL,FLOSSTIME INC (2017-01-24),https://lens.org/184-976-753-629-207,Patent Application,yes,8,2,1,5,0,A61C15/043;;A61C15/043,A61C15/04,,0,0,,,,DISCONTINUED
4,US,B2,US 10966488 B2,071-516-357-945-158,2021-04-06,2021,US 201916352750 A,2019-03-13,US 201916352750 A;;US 201862761173 P,2018-03-14,Shoe accessory system,"A shoe accessory system and methods can include: an accessory connector having a male accessory mount and a female accessory mount: the male accessory mount including a base, a protrusion mounted above the base, an outwardly protruding lip extending from the protrusion, the outwardly protruding lip having a slope extending down toward an abutment, and the female accessory mount having inwardly extending flanges, the inwardly extending flanges extend in toward a center of the female accessory mount, the inwardly extending flanges spaced apart allowing the protrusion to fit therebetween; a shoe affixed to the male accessory mount; and an accessory affixable to the female accessory mount for allowing the accessory to be placed over the male accessory mount, pressed down, and twisted to lock the accessory onto the shoe.",NGUYEN THUY DUONG;;NGUYEN DUC ANTOINE,NGUYEN THUY DUONG;;NGUYEN DUC ANTOINE,THRIVE INTERNATIONAL INC (2021-06-30);;BAUBLES AND SOLES INC (2021-09-07),https://lens.org/071-516-357-945-158,Granted Patent,yes,14,0,2,2,0,A43B3/30;;A43B23/24;;A43B3/30;;A43B23/24;;B29C45/14;;B29L2031/50,A43B23/24;;A43B3/30;;B29C45/14;;B29L31/50,,0,0,,,,ACTIVE
5,WO,A1,WO 2023/063758 A1,144-075-826-450-20X,2023-04-20,2023,KR 2022015535 W,2022-10-13,KR 20210136241 A,2021-10-14,"MONOCLONAL ANTIBODY SPECIFIC TO HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUS H5N1, AND RAPID DIAGNOSTIC KIT USING SAME","The present invention relates to a monoclonal antibody specific to highly pathogenic avian influenza virus H5N1, and a rapid diagnostic kit using same. Specifically, the present invention relates to: a monoclonal antibody E2C1 produced by a hybridoma cell line having the accession number of KCTC 14657BP or a monoclonal antibody 5B1 produced by a hybridoma cell line having the accession number of KCTC 14653BP; and a kit for rapidly diagnosing H5N1 by using same.",UNIV WONKWANG CT IND ACAD COOP;;SEOUL NAT UNIV R&DB FOUNDATION,PARK HYUN;;YEO SEON-JU;;THAN DUC DUONG;;DUONG TUAN BAO,,https://lens.org/144-075-826-450-20X,Patent Application,yes,4,0,3,3,4,C07K16/10;;G01N33/569;;C07K16/1018;;G01N33/56983;;G01N2333/11,C07K16/10;;G01N33/569,,1,0,,,"WONKWANG UNIVERSITY: ""Development of novel technology to detect highly pathogenic avian influenza in on-site monitoring system"", FINAL REPORT, WONKWANG UNIVERSITY, BIO·MEDICAL TECHNOLOGY DEVELOPMENT, KOREA, 30 September 2019 (2019-09-30), Korea, pages 1 - 32, XP009546457",PENDING
6,KR,A,KR 20230053089 A,074-057-220-767-820,2023-04-21,2023,KR 20210136241 A,2021-10-14,KR 20210136241 A,2021-10-14,H5N1 Monoclonal antibody specific to highly pathogenic avian influenza virus H5N1 and rapid diagnostic kit using the same,"본 발명은 고병원성 조류 인플루엔자 바이러스 H5N1에 특이적인 단클론항체 및 이를 이용한 신속 진단 키트에 관한 것으로, 구체적으로는 기탁번호가 KCTC 14657BP인 하이브리도마 세포주에 의하여 생산되는 단클론항체 E2C1 또는 기탁번호가 KCTC 14653BP인 하이브리도마 세포주에 의하여 생산되는 단클론항체 5B1 및 이를 이용한 H5N1 신속 진단 키트에 관한 것이다.",UNIV WONKWANG CT IND ACAD COOP;;SEOUL NAT UNIV R&DB FOUNDATION,PARK HYUN;;YEO SEON JU;;DUONG THAN DUC;;DUONG TUAN BAO,,https://lens.org/074-057-220-767-820,Patent Application,no,5,0,3,3,2,C07K16/10;;G01N33/569;;C07K16/1018;;G01N33/56983;;G01N2333/11,C07K16/10;;G01N33/569,,1,0,,,비특허문헌 1*,ACTIVE
7,FR,A1,FR 3127834 A1,100-071-022-442-322,2023-04-07,2023,FR 2110585 A,2021-10-06,FR 2110585 A,2021-10-06,Procédé de détermination d’un arrangement de panneaux photovoltaïques sur des zones d’un territoire,"Procédé de détermination d’un arrangement de panneaux photovoltaïques sur des zones d’un territoire La présente invention concerne un procédé de détermination d’un arrangement (A) de panneaux photovoltaïques sur des zones d’un territoire, dites zones cibles (ZC), le procédé comprenant : la réception d’une image vue du ciel du territoire, la détection de chaque zone cible (ZC) sur l’image de sorte à obtenir un masque de zones,l’application du masque de zones sur l’image pour obtenir une image cible,la détection de contours sur l’image cible pour obtenir un masque de contours, la combinaison du masque de zones et du masque de contours pour obtenir un masque d’obstacles, etla détermination d’un arrangement (A) de panneaux photovoltaïques sur chaque zone cible (ZC) de l’image en fonction du masque d’obstacles de sorte que chaque panneau photovoltaïque recouvre une portion d’une zone cible (ZC) dépourvue d’obstacles (O). Figure pour l'abrégé : 3",TOTALENERGIES SE,POULAIN GILLES;;LE BORGNE EMMANUEL;;DUONG DUC NGUYEN,,https://lens.org/100-071-022-442-322,Patent Application,no,1,0,2,2,0,G06T7/75;;G06T17/05;;G06T2207/10032;;G06T2207/30184;;G06T2210/04;;G06Q50/06;;G06Q10/103;;G06Q10/04,G06T7/00;;G06Q50/06;;G06T7/11;;G06T7/13,,0,0,,,,DISCONTINUED
8,US,S,US D0805693 S,124-621-763-172-037,2017-12-19,2017,US 201529543732 F,2015-10-27,US 201529543732 F;;US 201514835498 A,2015-08-25,Floss dispenser,,FLOSSTIME INC,EVANS MICHAEL;;DUONG DUC;;FARIA GREGORIO;;LOEW CHRISTOPHER,FLOSSTIME INC (2015-11-04),https://lens.org/124-621-763-172-037,Design Right,no,0,2,1,1,0,,,2803;;D28/66,0,0,,,,ACTIVE
9,WO,A1,WO 2023/057505 A1,076-801-290-339-851,2023-04-13,2023,EP 2022077687 W,2022-10-05,FR 2110585 A,2021-10-06,METHOD FOR DETERMINING AN ARRANGEMENT OF PHOTOVOLTAIC PANELS IN ZONES OF A TERRITORY,"The present invention relates to a method for determining an arrangement (A) of photovoltaic panels in zones of a territory that are referred to as target zones (Z C ), the method comprising: a. receiving an image of a bird's-eye view of the territory, b. detecting each target zone (Z C ) in the image so as to obtain a zone mask, c. applying the zone mask to the image to obtain a target image, d. detecting edges in the target image to obtain an edge mask, e. combining the zone mask and the edge mask to obtain an obstacle mask, and f. determining an arrangement (A) of photovoltaic panels in each target zone (Z C ) of the image depending on the obstacle mask so that each photovoltaic panel covers a segment of a target zone (Z C ) that is devoid of obstacles (O).",TOTALENERGIES ONETECH,POULAIN GILLES;;LE BORGNE EMMANUEL;;DUONG DUC NGUYEN,,https://lens.org/076-801-290-339-851,Patent Application,yes,1,0,2,2,0,G06T7/75;;G06T17/05;;G06T2207/10032;;G06T2207/30184;;G06T2210/04;;G06Q50/06;;G06Q10/103;;G06Q10/04,G06T7/73;;G06T17/05,,0,0,,,,PENDING
10,WO,A1,WO 2022/045792 A1,043-514-619-604-595,2022-03-03,2022,KR 2021011436 W,2021-08-26,KR 20200109669 A,2020-08-28,"MONOCLONAL ANTIBODY SPECIFIC TO HIGHLY PATHOGENIC AVIAN INFLUENZA H5 SUBTYPE, AND RAPID DIAGNOSTIC KIT USING SAME","The present invention relates to a monoclonal antibody specific to the highly pathogenic avian influenza virus H5 subtype, and to a rapid diagnostic kit using same. Specifically, the present invention relates to a method for detecting H5 subtype influenza virus by using a monoclonal antibody produced by a hybridoma cell line having accession number KCTC14277BP, or a monoclonal antibody produced by a hybridoma cell line having accession number KCTC14278BP.",UNIV WONKWANG CT IND ACAD COOP,YEO SEON-JU;;PARK HYUN;;DUONG TUAN BAO;;TRINH THI THUY TIEN;;THAN DUC DUONG,,https://lens.org/043-514-619-604-595,Patent Application,yes,4,0,3,3,1,C12N5/12;;C07K16/10;;G01N33/558;;G01N33/569;;G01N33/577;;C07K16/1018;;C12N5/12;;G01N33/56983;;G01N33/558;;G01N33/577;;G01N2333/11,C07K16/10;;C12N5/12;;G01N33/558;;G01N33/569;;G01N33/577,,1,1,030-269-529-073-622,pmc5546692;;10.1371/journal.pone.0182228;;28787440,"NGUYEN LAM THANH, NAKAISHI KAZUNARI, MOTOJIMA KEIKO, OHKAWARA AYAKO, MINATO ERINA, MARUYAMA JUNKI, HIONO TAKAHIRO, MATSUNO KEITA, : ""Rapid and broad detection of H5 hemagglutinin by an immunochromatographic kit using novel monoclonal antibody against highly pathogenic avian influenza virus belonging to the genetic clade 2.3.4.4"", PLOS ONE, vol. 12, no. 8, pages e0182228, XP055903970, DOI: 10.1371/journal.pone.0182228",PENDING
11,US,A1,US 2021/0366663 A1,068-579-932-491-421,2021-11-25,2021,US 202117316457 A,2021-05-10,VN 202002943 A,2020-05-25,Ultracapacitor power system,"The invention offers an ultracapacitor-based power system solution with four main functional blocks which are power conditioning block, monitoring block, charge-discharge block and protection block. The proposed system has the advantage of working well in the environment of vibration, high temperature, has a large capacity to provide a large amount and radiates less heat compared to systems using traditional batteries. In addition, the system has functions to protect and stabilize the output voltage, and the operating parameters of the system is monitored continuously.",VIETTEL GROUP,DUONG TRUONG GIANG;;NGUYEN CANH DUONG;;NGUYEN DUC ANH;;VUONG XUAN CHIEN;;TRAN PHUONG NAM,VIETTEL GROUP (2021-05-06),https://lens.org/068-579-932-491-421,Patent Application,yes,2,0,1,1,0,Y02E60/13;;H02J2207/50;;H02J7/0031;;H02J7/0047;;H02J7/0042;;H02J7/00032;;F02N2011/0885;;H01G11/08;;H01G11/14;;H01G11/84;;H01G11/08;;H01G11/14;;F02N2011/0885;;H01G9/14;;H02J7/345;;H01G11/84,H01G11/08;;H01G9/14;;H01G11/14;;H01G11/84;;H02J7/34,,0,0,,,,PENDING
12,KR,A,KR 20220028545 A,122-113-508-031-516,2022-03-08,2022,KR 20200109669 A,2020-08-28,KR 20200109669 A,2020-08-28,H5 Monoclonal antibody specific to highly pathogenic avian influenza virus H5 subtype and rapid diagnostic kit using the same,"The present invention relates to a monoclonal antibody specific to the highly pathogenic avian influenza virus H5 subtype and a rapid diagnostic kit using the same, and specifically, a method for detecting H5 subtype influenza virus using a monoclonal antibody produced by a hybridoma cell line having an accession number KCTC14277BP or a hybridoma cell line having an accession number KCTC14278BP.",UNIV WONKWANG CT IND ACAD COOP,YEO SEON JU;;PARK HYUN;;DUONG TUAN BAO;;TRINH THI THUY TIEN;;THAN DUC DUONG,,https://lens.org/122-113-508-031-516,Patent Application,no,4,0,3,3,2,C12N5/12;;C07K16/10;;G01N33/558;;G01N33/569;;G01N33/577;;C07K16/1018;;C12N5/12;;G01N33/56983;;G01N33/558;;G01N33/577;;G01N2333/11,C07K16/10;;C12N5/12;;G01N33/558;;G01N33/569;;G01N33/577,,1,0,,,"PLOS One, 2017년, 12권, 8호, e0182228, 내부페이지 1-11*",ACTIVE
13,US,A1,US 2019/0162838 A1,097-355-281-863-373,2019-05-30,2019,US 201816198967 A,2018-11-23,VN 201704786 A,2017-11-28,MARINE TARGET DETECTION IN CLUTTERED ENVIRONMENTS,Method of slowly moving target detection with application for coastal surveillance radars. This method improves the well know other methods and efficiently detects targets with a high accuracy. The proposed method consists of three steps that are: step of generation and processing of signals with complex modulation; step of target clustering and step of detection of slowly moving targets in clutter environments.,VIETTEL GROUP,LUU HOAI NAM;;TRAN VU HOP;;DONG XUAN HOANG;;NGUYEN DUC DUONG;;LE TRUNG DUC,VIETTEL GROUP (2018-11-19),https://lens.org/097-355-281-863-373,Patent Application,yes,3,7,2,2,0,G01S7/414;;G01S13/5244;;G01S13/5248;;G01S13/5246;;G01S13/5244;;G01S13/5248;;G01S13/5246;;G01S7/414,G01S13/524,,0,0,,,,ACTIVE
14,US,B2,US 10802130 B2,041-294-347-332-498,2020-10-13,2020,US 201816198967 A,2018-11-23,VN 201704786 A,2017-11-28,Marine target detection in cluttered environments,Method of slowly moving target detection with application for coastal surveillance radars. This method improves the well know other methods and efficiently detects targets with a high accuracy. The proposed method consists of three steps that are: step of generation and processing of signals with complex modulation; step of target clustering and step of detection of slowly moving targets in clutter environments.,VIETTEL GROUP,LUU HOAI NAM;;TRAN VU HOP;;DONG XUAN HOANG;;NGUYEN DUC DUONG;;LE TRUNG DUC,VIETTEL GROUP (2018-11-19),https://lens.org/041-294-347-332-498,Granted Patent,yes,6,0,2,2,0,G01S7/414;;G01S13/5244;;G01S13/5248;;G01S13/5246;;G01S13/5244;;G01S13/5248;;G01S13/5246;;G01S7/414,G01S13/524;;G01S7/41,,0,0,,,,ACTIVE
15,WO,A3,WO 2016/033109 A3,173-840-423-545-834,2016-04-21,2016,US 2015/0046794 W,2015-08-25,US 201462070388 P;;US 201462124302 P,2014-08-25,FLOSS DISPENSERS,"Floss dispensers are described. In one embodiment, a floss dispenser includes a housing and a feeder coupled to the housing. The feeder is configured to feed a length of floss from a spool of floss. The floss dispenser also includes a spout formed in the housing having a cutter entry and a cutter exit. A cutter is coupled to the housing between the cutter entry and the cutter exit. The spout is configured to guide the length of floss to the cutter. In another embodiment, a floss dispenser includes a housing and a reminder display. The reminder display may include a plurality of reminder lights coupled to the housing configured to display a reminder to floss to a user. The floss dispenser also includes a timer connected to the reminder display that is configured to determine whether a predetermined period of time has passed since the user last flossed.",FLOSSTIME INC,EVANS MICHAEL;;DUONG DUC;;FARIA GREGORIO;;GRIMM THOMAS;;LOEW CHRISTOPHER,,https://lens.org/173-840-423-545-834,Search Report,yes,7,0,4,5,0,A61C15/043;;A61C15/043,A61C15/04,,3,0,,,"DISPENSER9: ""Toothpaste Dispenser & Dental Floss & Toothbruches (3 in 1"", 18 November 2015 (2015-11-18), Retrieved from the Internet <URL:https://www.youtube.com/watch?v=klu9ilmu1yA> [retrieved on 20090629];;MARCELMBV: ""Dental Floss Dispenser"", 18 November 2015 (2015-11-18), Retrieved from the Internet <URL:https://www.youtube.com/watch?v=wWHacUNkCxM> [retrieved on 20070315];;IOY I: ""The IOY I Mountable Dental Floss Dispenser"", 18 November 2015 (2015-11-18), Retrieved from the Internet <URL:https://www.youtube.com/watch?v=yO_VgLPKgR4> [retrieved on 20140217]",PENDING
16,US,A1,US 2016/0051351 A1,186-878-096-573-883,2016-02-25,2016,US 201514835498 A,2015-08-25,US 201514835498 A;;US 201462070388 P;;US 201462124302 P,2014-08-25,FLOSS DISPENSERS,"Floss dispensers are described. In one embodiment, a floss dispenser includes a housing and a feeder coupled to the housing. The feeder may be configured to feed a length of floss from a spool of floss. The floss dispenser also includes a spout formed in the housing. The spout may have a cutter entry and a cutter exit. The floss dispenser also includes a cutter coupled to the housing. The cutter may be coupled to the housing between the cutter entry and the cutter exit. The spout may be configured to guide the length of floss to the cutter. In another embodiment, a floss dispenser includes a housing and a reminder display. The reminder display may include a plurality of reminder lights coupled to the housing. The reminder lights may be configured to display a reminder to floss to a user. The floss dispenser also includes a timer connected to the reminder display. The timer may be configured to determine whether a predetermined period of time has passed since the user last flossed.",FLOSSTIME INC,EVANS MICHAEL;;DUONG DUC;;FARIA GREGORIO;;GRIMM THOMAS;;LOEW CHRISTOPHER,FLOSSTIME INC (2015-11-04),https://lens.org/186-878-096-573-883,Patent Application,yes,19,3,4,5,0,A61C15/043;;A61C15/043,A61C15/04,,0,0,,,,INACTIVE
17,US,B2,US 10376345 B2,069-847-091-918-527,2019-08-13,2019,US 201514835498 A,2015-08-25,US 201514835498 A;;US 201462070388 P;;US 201462124302 P,2014-08-25,Floss dispensers,"Floss dispensers are described. In one embodiment, a floss dispenser includes a housing and a feeder coupled to the housing. The feeder may be configured to feed a length of floss from a spool of floss. The floss dispenser also includes a spout formed in the housing. The spout may have a cutter entry and a cutter exit. The floss dispenser also includes a cutter coupled to the housing. The cutter may be coupled to the housing between the cutter entry and the cutter exit. The spout may be configured to guide the length of floss to the cutter.",FLOSSTIME INC,EVANS MICHAEL;;DUONG DUC;;FARIA GREGORIO;;GRIMM THOMAS;;LOEW CHRISTOPHER,FLOSSTIME INC (2015-11-04),https://lens.org/069-847-091-918-527,Granted Patent,yes,36,3,4,5,0,A61C15/043;;A61C15/043,A61C15/04,,4,0,,,"Dispenser9, “Toothpaste Dispenser & Dental Floss & Toothbrushes (3 in 1)” [online], uploaded on Jun. 29, 2009 (Jun. 29, 2009), https://www.youtube.com/watch?v= klu9ilmu1yA.;;Marcelmbv, “Dental Floss Dispenser” [online], uploaded on Mar. 15, 2007 (Mar. 15, 2007), https://www.youtube.com/watch?v=wWHacUNkCxM.;;TOYT, “The TOYT Mountable Dental Floss Dispenser” [online], uploaded on Feb. 17, 2014 (Feb. 17, 2014), https://www.youtube.com/watch?v=yO_VgLPKgR4.;;PCT application PCT/US2015/046794, Feb. 16, 2016 ISR/WO.",INACTIVE
18,US,A1,US 2021/0262006 A1,159-517-082-099-508,2021-08-26,2021,US 201917254032 A,2019-06-18,US 201917254032 A;;US 201862686385 P;;US 2019/0037788 W,2018-06-18,Parallel Enzyme Digestion for Protein Biomarker Detection,This disclosure relates to isotopically labeled internal standards that can be digested by an enzyme capable of C-terminal cleavage of a first amino acid and/or an enzyme capable of N-terminal cleavage of a second amino acid useful to generate standards for the measurement of quantities of peptides of interest in a sample.,UNIV EMORY,SEYFRIED NICHOLAS;;DUONG DUC;;LEVEY ALLAN;;ZHOU MAOTIAN;;LAH JAMES,EMORY UNIVERSITY (2019-04-22),https://lens.org/159-517-082-099-508,Patent Application,yes,1,0,2,2,45,C12Q1/37;;G01N33/6848;;G01N2800/2821;;C07K14/4711;;C07K14/4711;;C12Q1/37;;G01N33/6848;;G01N33/6896;;G01N2800/2814;;G01N2800/2821,C07K14/47;;C12Q1/37;;G01N33/68,,0,0,,,,PENDING
19,WO,A2,WO 2016/033109 A2,041-353-630-249-734,2016-03-03,2016,US 2015/0046794 W,2015-08-25,US 201462070388 P;;US 201462124302 P,2014-08-25,FLOSS DISPENSERS,"Floss dispensers are described. In one embodiment, a floss dispenser includes a housing and a feeder coupled to the housing. The feeder may be configured to feed a length of floss from a spool of floss. The floss dispenser also includes a spout formed in the housing. The spout may have a cutter entry and a cutter exit. The floss dispenser also includes a cutter coupled to the housing. The cutter may be coupled to the housing between the cutter entry and the cutter exit. The spout may be configured to guide the length of floss to the cutter. In another embodiment, a floss dispenser includes a housing and a reminder display. The reminder display may include a plurality of reminder lights coupled to the housing. The reminder lights may be configured to display a reminder to floss to a user. The floss dispenser also includes a timer connected to the reminder display. The timer may be configured to determine whether a predetermined period of time has passed since the user last flossed.",FLOSSTIME INC,EVANS MICHAEL;;DUONG DUC;;FARIA GREGORIO;;GRIMM THOMAS;;LOEW CHRISTOPHER,,https://lens.org/041-353-630-249-734,Patent Application,yes,0,0,4,5,0,A61C15/043;;A61C15/043,A61C15/04,,0,0,,,,PENDING
20,WO,A1,WO 2024/044763 A1,166-500-047-809-36X,2024-02-29,2024,US 2023/0072936 W,2023-08-25,US 202263401551 P,2022-08-26,MASS SPECTROMETRY ANALYSIS OF MARKERS FOR ALZHEIMER'S DISEASE,"Provided herein is a sensitive, quantitative,, and scalable targeted proteomics assay of Alzheimer's Disease biomarkers representing neuronal, glial, vasculature and metabolic pathways. The biomarkers are protease-digested peptides selected from biological samples of individuals having normal Aβ and Tau levels (AT-) and from symptomatic and asymptomatic individuals having low Aβ and high Tau levels (AT+). The assay uses selective reaction monitoring- based mass spectrometry (SRM-MS) of peptides in the biological samples after digestion.",UNIV EMORY,SEYFRIED NICHOLAS;;DUONG DUC;;LEVEY ALLAN;;LAH JAMES;;WATSON CAROLINE,,https://lens.org/166-500-047-809-36X,Patent Application,yes,1,0,1,1,0,G01N33/6896;;G01N33/6848;;G01N2800/52;;G01N2800/60;;G01N2800/2821;;G01N2800/56,G01N33/68,,10,0,,,"MAOTIAN ZHOU ET AL: ""Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer's disease"", CLINICAL PROTEOMICS, SPRINGER, US, vol. 17, no. 1, 29 May 2020 (2020-05-29), pages 1 - 14, XP021277181, ISSN: 1542-6416, DOI: 10.1186/S12014-020-09285-8;;HIGGINBOTHAM LENORA ET AL: ""Integrated Proteomics Reveals Brain-Based Cerebrospinal Fluid Biomarkers in Asymptomatic and Symptomatic Alzheimer's Disease"", BIORXIV, 12 November 2019 (2019-11-12), pages 1 - 45, XP055836480, Retrieved from the Internet <URL:https://www.biorxiv.org/content/10.1101/806752v2.full> [retrieved on 20210831], DOI: 10.1101/806752;;DANIEL S. SPELLMAN ET AL: ""Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF"", PROTEOMICS CLINICAL APPLICATIONS, vol. 9, no. 7-8, 24 April 2015 (2015-04-24), DE, pages 715 - 731, XP055381013, ISSN: 1862-8346, DOI: 10.1002/prca.201400178;;JOHNSON ERIK C B ET AL: ""Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation"", NATURE MEDICINE, NATURE PUBLISHING GROUP US, NEW YORK, vol. 26, no. 5, 13 April 2020 (2020-04-13), pages 769 - 780, XP037113594, ISSN: 1078-8956, [retrieved on 20200413], DOI: 10.1038/S41591-020-0815-6;;MICHAUD SARAH A. ET AL: ""Molecular phenotyping of laboratory mouse strains using 500 multiple reaction monitoring mass spectrometry plasma assays"", COMMUNICATIONS BIOLOGY, vol. 1, no. 1, 27 June 2018 (2018-06-27), pages 1 - 9, XP093100625, Retrieved from the Internet <URL:https://www.nature.com/articles/s42003-018-0087-6> DOI: 10.1038/s42003-018-0087-6;;SCOTT M. LUNDBERG ET AL: ""From local explanations to global understanding with explainable AI for trees"", NATURE MACHINE INTELLIGENCE, vol. 2, no. 1, 17 January 2020 (2020-01-17), pages 56 - 67, XP055756937, DOI: 10.1038/s42256-019-0138-9;;LEVEY ALLAN I ET AL: ""A PROOF OF CONCEPT PHASE II STUDY REPURPOSING ATOMOXETINE FOR NEUROPROTECTION IN MILD COGNITIVE IMPAIRMENT: EVIDENCE FOR TARGET ENGAGEMENT, REGULATION OF CSF BIOMARKERS, AND DISEASE-MODIFYING POTENTIAL"", ALZHEIMER'S & DEMENTIA, ELSEVIER, NEW YORK, NY, US, vol. 15, no. 7, 1 July 2019 (2019-07-01), XP085869985, ISSN: 1552-5260, [retrieved on 20191018], DOI: 10.1016/J.JALZ.2019.06.4804;;BLANCHARD VALENTIN ET AL: ""Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study"", JOURNAL OF LIPID RESEARCH, vol. 59, no. 5, 14 March 2018 (2018-03-14), US, pages 892 - 900, XP093102229, ISSN: 0022-2275, DOI: 10.1194/jlr.P083576;;WATSON CAROLINE M. ET AL: ""Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer's Disease"", SCIENTIFIC DATA, vol. 10, no. 1, 9 May 2023 (2023-05-09), pages 1 - 14, XP093100640, Retrieved from the Internet <URL:https://www.nature.com/articles/s41597-023-02158-3> DOI: 10.1038/s41597-023-02158-3;;LUNDBERG ET AL.: ""From local explanations to global understanding with explainable AI for trees."", NATURE MACHINE INTELLIGENCE, vol. 2, 2020, pages 56 - 67, XP055756937, DOI: 10.1038/s42256-019-0138-9",PENDING
21,US,A1,US 2024/0068783 A1,017-352-144-353-611,2024-02-29,2024,US 202318358234 A,2023-07-25,VN 1202205576 A,2022-08-31,METHOD FOR DETERMINING POSITION OF A LASER POINT APPLIED IN A FIREARM TRAINING SIMULATION SYSTEM USING INFRARED LASERS,"A method to detect, identify and determine the position of laser points from infrared laser emitters in a firearm training simulation system. The method consists of two steps. This first step combines some common tools such as a camera with a filter switcher and edge and corner detecting algorithms in image processing to provide a fast automatic screen calibrating method. The second step is to detect laser point objects in each frame continuously captured by the camera, and then further process these objects to identify laser shots, filter out noisy objects, and eventually detect simulated shots from different laser emitters and determine the final mapped position of the shot.",VIETTEL GROUP,VU ANH TUAN;;NGUYEN DUC THANH;;HA VAN DUC;;HOANG KIM DUC;;NGUYEN THANH NHON;;DUONG ANH TRA;;NGUYEN TRAN NAM,VIETTEL GROUP (2023-05-26),https://lens.org/017-352-144-353-611,Patent Application,yes,0,0,1,1,0,F41G3/2655;;G06V2201/07;;G06V20/80;;G06V20/44,G06V20/40;;F41G3/26;;G06V20/80,,0,0,,,,PENDING
22,GB,A,GB 2612949 A,000-280-970-966-199,2023-05-24,2023,GB 202114645 A,2021-10-13,GB 202114645 A,2021-10-13,Biofilm removal,"A cleaning mixture for removing biofilm from surfaces comprises water and silver particles or particles surface modified with silver. The mixture further comprises manganese dioxide particles or particles e.g. zeolite, surface modified with manganese oxide. The mixture may further comprise hydrogen peroxide. Also shown is a method of removing a biofilm using the cleaning mixture.",PARTNERSHIP MEDICAL LTD,ROBERT JOHN HARTLEY;;THIEN DUC DUONG;;ANDREW JAMES SUTHERLAND;;TONY WORTHINGTON,,https://lens.org/000-280-970-966-199,Patent Application,no,2,0,3,3,0,C11D7/02;;C11D2111/20;;C11D7/02;;B08B9/027;;C11D3/1213;;C11D7/20;;C11D17/0013;;A61B2090/701,C11D7/02;;B08B9/027;;C11D3/12;;C11D7/20;;C11D17/00,,0,0,,,,PENDING
23,WO,A1,WO 2019/246140 A1,076-069-131-009-965,2019-12-26,2019,US 2019/0037788 W,2019-06-18,US 201862686385 P,2018-06-18,PARALLEL ENZYME DIGESTION FOR PROTEIN BIOMARKER DETECTION,This disclosure relates to isotopically labeled internal standards that can be digested by an enzyme capable of C-terminal cleavage of a first amino acid and/or an enzyme capable of N-terminal cleavage of a second amino acid useful to generate standards for the measurement of quantities of peptides of interest in a sample.,UNIV EMORY,SEYFRIED NICHOLAS T;;DUONG DUC;;LEVEY ALLAN;;ZHOU MAOTIAN;;LAH JAMES,,https://lens.org/076-069-131-009-965,Patent Application,yes,4,0,2,2,45,C12Q1/37;;G01N33/6848;;G01N2800/2821;;C07K14/4711;;C07K14/4711;;C12Q1/37;;G01N33/6848;;G01N33/6896;;G01N2800/2814;;G01N2800/2821,A61K38/00;;B01D59/44;;C07K7/00;;C12Q1/37;;G01N33/60,,2,2,003-117-117-035-644;;102-460-445-769-417,30983353;;10.1021/acs.jproteome.8b00920;;10.1016/j.aca.2014.06.024;;25086887,"ZHOU ET AL.: ""Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide Standard"", J PROTEOME RES, vol. 18, no. 6, 15 April 2019 (2019-04-15), pages 2422 - 2432, XP055664886;;KIM ET AL.: ""Detection and quantification of plasma amyloid-beta by selected reaction monitoring mass spectrometry"", ANAL CHIM ACTA, vol. 840, 17 June 2014 (2014-06-17), pages 1 - 9, XP029012652",PENDING
24,WO,A1,WO 2023/062337 A1,189-869-639-889-994,2023-04-20,2023,GB 2022052505 W,2022-10-04,GB 202114645 A,2021-10-13,BIOFILM REMOVAL,A cleaning mixture for removing biofilm from surfaces. The cleaning mixture comprises water and silver particles or particles surface modified with silver. The mixture further comprises manganese oxide particles or particles surface modified with manganese oxide.,PARTNERSHIP MEDICAL LTD,HARTLEY ROBERT JOHN;;DUONG THIEN DUC;;SUTHERLAND ANDREW JAMES;;WORTHINGTON TONY,,https://lens.org/189-869-639-889-994,Patent Application,yes,2,0,3,3,0,C11D7/02;;C11D2111/20;;C11D7/02;;B08B9/027;;C11D3/1213;;C11D7/20;;C11D17/0013;;A61B2090/701,C11D11/00;;C11D7/02,,0,0,,,,PENDING
25,US,B2,US 11776191 B2,064-989-243-512-211,2023-10-03,2023,US 202217747833 A,2022-05-18,VN 1202104762 A,2021-07-30,System and method for reconstructing a 3D human body using compact kit of depth cameras,"The invention presents a system and a method for 3D human reconstruction using a compact kit of depth cameras. Instead of using complex and expensive devices as in traditional methods, the proposed system and method employs a simple, easy-to-install system to accurately collect the human body shape. The generated model is capable of moving thanks to a skeleton system simulating the human skeleton. The proposed system includes four blocks: Data Collection Block, Point Cloud Standardization Block, Human Digitization Block and Output Block. The proposed method includes five steps: Point Cloud Collecting, Point Cloud Filtering, Point Cloud Calibrating, Point Cloud Optimizing and 3D Human Model Generating.",VIETTEL GROUP,TRAN VAN DUC;;NGUYEN TIEN DAT;;NGUYEN HAI ANH;;DUONG ANH TRA,VIETTEL GROUP (2021-12-08),https://lens.org/064-989-243-512-211,Granted Patent,yes,1,0,2,2,0,G06T17/00;;G06T13/40;;G06T7/593;;G06T2207/10012;;G06T2207/20081;;G06T2207/20084;;G06T2207/30196;;H04N13/271;;G06T13/40;;G06T2207/30196;;H04N13/239;;G06T7/70;;G06T5/20;;H04N13/111;;G06T7/80;;G06T7/60;;G06T2207/10028;;G06T2207/30244;;G06T2210/56;;G06T2207/20081;;G06T2200/04;;G06T2207/10012;;G06T17/20;;G06T5/70,G06T13/40;;G06T5/00;;G06T5/20;;G06T7/60;;G06T7/70;;G06T7/80;;G06T17/20;;H04N13/111;;H04N13/239,,0,0,,,,ACTIVE
26,US,B2,US 11448661 B2,179-053-032-728-460,2022-09-20,2022,US 202016732896 A,2020-01-02,VN 1201900036 A,2019-01-03,Coaxial angular velocity sensor system,"The Coaxial Angular Velocity Sensor System is an electronic sensor, which processes and supplies the output signal of the inertial angular velocity with high accuracy and great reliability. The device consists of the main components: angular velocity sensor, analog-digital converter, microcontroller, temperature sensor, power source, mechanical anti-noise-proof chassis. The device's microprocessor comes with a signal processing algorithm that helps increase the accuracy of the device's output. Because of its compact size, high precision, and low cost, the device is used in high precision devices such as UAV cameras, or in life applications such as self-balancing vehicles.",VIETTEL GROUP,MAC LUU PHONG;;NGUYEN VAN TAM;;DUONG DUC BANG;;PHAM VAN TIEN,VIETTEL GROUP (2019-12-28),https://lens.org/179-053-032-728-460,Granted Patent,yes,3,0,2,2,0,G01C19/5776;;G01C19/5783;;G01C21/166;;G01P3/4802;;G01P3/489;;G01P15/14,G01P3/48;;G01P3/489;;G01P15/14,,0,0,,,,ACTIVE
27,US,A1,US 2020/0217871 A1,016-020-731-120-09X,2020-07-09,2020,US 202016732896 A,2020-01-02,VN 1201900036 A,2019-01-03,Coaxial Angular Velocity Sensor System,"The Coaxial Angular Velocity Sensor System is an electronic sensor, which processes and supplies the output signal of the inertial angular velocity with high accuracy and great reliability. The device consists of the main components: angular velocity sensor, analog-digital converter, microcontroller, temperature sensor, power source, mechanical anti-noise-proof chassis. The device's microprocessor comes with a signal processing algorithm that helps increase the accuracy of the device's output. Because of its compact size, high precision, and low cost, the device is used in high precision devices such as UAV cameras, or in life applications such as self-balancing vehicles.",VIETTEL GROUP,MAC LUU PHONG;;NGUYEN VAN TAM;;DUONG DUC BANG;;PHAM VAN TIEN,VIETTEL GROUP (2019-12-28),https://lens.org/016-020-731-120-09X,Patent Application,yes,0,3,2,2,0,G01C19/5776;;G01C19/5783;;G01C21/166;;G01P3/4802;;G01P3/489;;G01P15/14,G01P3/48;;G01P3/489,,0,0,,,,ACTIVE
28,US,A1,US 2023/0033542 A1,076-759-664-786-888,2023-02-02,2023,US 202217747833 A,2022-05-18,VN 1202104762 A,2021-07-30,SYSTEM AND METHOD FOR RECONSTRUCTING A 3D HUMAN BODY USING COMPACT KIT OF DEPTH CAMERAS,"The invention presents a system and a method for 3D human reconstruction using a compact kit of depth cameras. Instead of using complex and expensive devices as in traditional methods, the proposed system and method employs a simple, easy-to-install system to accurately collect the human body shape. The generated model is capable of moving thanks to a skeleton system simulating the human skeleton. The proposed system includes four blocks: Data Collection Block, Point Cloud Standardization Block, Human Digitization Block and Output Block. The proposed method includes five steps: Point Cloud Collecting, Point Cloud Filtering, Point Cloud Calibrating, Point Cloud Optimizing and 3D Human Model Generating.",VIETTEL GROUP,TRAN VAN DUC;;NGUYEN TIEN DAT;;NGUYEN HAI ANH;;DUONG ANH TRA,VIETTEL GROUP (2021-12-08),https://lens.org/076-759-664-786-888,Patent Application,yes,1,0,2,2,0,G06T17/00;;G06T13/40;;G06T7/593;;G06T2207/10012;;G06T2207/20081;;G06T2207/20084;;G06T2207/30196;;H04N13/271;;G06T13/40;;G06T2207/30196;;H04N13/239;;G06T7/70;;G06T5/20;;H04N13/111;;G06T7/80;;G06T7/60;;G06T2207/10028;;G06T2207/30244;;G06T2210/56;;G06T2207/20081;;G06T2200/04;;G06T2207/10012;;G06T17/20;;G06T5/70,G06T13/40;;G06T5/00;;G06T5/20;;G06T7/60;;G06T7/70;;G06T7/80;;G06T17/20;;H04N13/111;;H04N13/239,,0,0,,,,ACTIVE
29,KR,A,KR 20230161666 A,154-182-560-867-927,2023-11-28,2023,KR 20220061311 A,2022-05-19,KR 20220061311 A,2022-05-19,Apparatus for Fastening rivet,"리벳 체결 장치가 개시된다. 개시된 장치는 좌우로 이동 가능한 좌측 상부 그리퍼와 좌우로 이동 가능한 우측 상부 그리퍼를 포함하는 제1 그리퍼; 및 상기 제1 그리퍼 하부에 위치하며 좌우로 이동 가능한 좌측 하부 그리퍼와 상기 제1 그리퍼 하부에 위치하며 좌우로 이동 가능한 우측 하부 그리퍼를 포함하는 제2 그리퍼를 포함하되, 상기 제1 그리퍼가 닫힌 상태에서 상기 제1 그리퍼는 공급된 리벳의 헤드를 고정시키고 상기 제2 그리퍼가 닫힌 상태에서 상기 제2 그리퍼는 상기 리벳의 몸통부를 고정한다. 개시된 장치에 의하면 그리퍼가 리벳을 정확히 수직으로 정렬하여 체결 정확도를 향상시킬 수 있으며, 작업자의 손목 피로도를 최소화하고 주변 장애물이 존재하는 환경에서도 리벳 체결이 가능한 장점이 있다.",ACE TECH CORP,JEON DON GUK;;SONG HEE JIN;;DO THANH LUAN;;DUONG MINH DUC,,https://lens.org/154-182-560-867-927,Patent Application,no,0,0,1,1,0,B21J15/105;;B21J15/041;;B21J15/16,B21J15/10;;B21J15/04;;B21J15/16,,0,0,,,,PENDING
30,WO,A1,WO 2020/072404 A1,104-974-822-020-577,2020-04-09,2020,US 2019/0053937 W,2019-10-01,US 201862739580 P,2018-10-01,METHOD AND DEVICE FOR DETERMINING SONIC SLOWNESS,"Sonic logging data including a sonic waveform associated with a plurality of shot gathers is accessed. A transformation operator is applied to the sonic logging data to provide a transformed sonic image, the transformation operator including at least one of a short time average long time average (STA/LTA) operator, a phase shift operator, and a deconvolution operator. A machine learning process is performed using the transformed sonic image to determine a sonic slowness associated with the sonic logging data. The sonic slowness is provided as an output.",SCHLUMBERGER TECHNOLOGY CORP;;SCHLUMBERGER CA LTD;;SERVICES PETROLIERS SCHLUMBERGER;;GEOQUEST SYSTEMS BV,KHADHRAOUI BASSEM;;LAM LU DUC DUONG;;AKKURT RIDVAN;;YAMAMOTO HIROAKI;;WIELEMAKER ERIK;;KISRA SAAD,,https://lens.org/104-974-822-020-577,Patent Application,yes,7,0,8,8,0,G01V1/50;;G01V1/42;;G01V2210/6222;;G01V1/303;;G06N3/08;;G06N3/045;;G01V1/303;;G01V1/345;;G01V2210/6222;;G06N3/04,G01V1/48;;E21B41/00;;E21B47/00;;G01V1/50;;G06N20/00,,1,0,,,See also references of EP 3861378A4,PENDING
31,US,B2,US 11914089 B2,067-965-171-661-615,2024-02-27,2024,US 201917250941 A,2019-10-01,US 201917250941 A;;US 201862739580 P;;US 2019/0053937 W,2018-10-01,Method and device for determining sonic slowness,"Sonic logging data including a sonic waveform associated with a plurality of shot gathers is accessed. A transformation operator is applied to the sonic logging data to provide a transformed sonic image, the transformation operator including at least one of a short time average long time average (STA/LTA) operator, a phase shift operator, and a deconvolution operator. A machine learning process is performed using the transformed sonic image to determine a sonic slowness associated with the sonic logging data. The sonic slowness is provided as an output.",SCHLUMBERGER TECHNOLOGY CORP,KHADHRAOUI BASSEM;;LAM LU DUC DUONG;;AKKURT RIDVAN;;YAMAMOTO HIROAKI;;WIELEMAKER ERIK;;KISRA SAAD,SCHLUMBERGER TECHNOLOGY CORPORATION (2019-11-01),https://lens.org/067-965-171-661-615,Granted Patent,yes,12,0,8,8,0,G01V1/50;;G01V1/42;;G01V2210/6222;;G01V1/303;;G06N3/08;;G06N3/045;;G01V1/303;;G01V1/345;;G01V2210/6222;;G06N3/04,G01V1/30;;G01V1/34;;G06N3/04,,12,0,,,"Valero, H.-P. et al., High resolution compressional slowness log estimation using first motion detection, SEG/Houston 2005 Annual Meeting, pp. 356-360.;;Khadhraoui B., Kisra S. and Nguyen H.M.T., A New Algorithm for High Depth Resolution Slowness Estimate on Sonic-Array Waveforms, SPWLA 59th Annual Logging Symposium, Jun. 2-6, 2018, London, UK, 10 pages.;;Kimball, C., V. and Marzetta, T., Semblance processing of borehole acoustic array data, Geophysics,49(3), Mar. 1984, 274-281. https://doi.org/10.1190/1.441659.;;Kimball, C. V., Shear slowness measurement by dispersive processing of the borehole flexural mode, Geophysics vol. 63, Issue 2, Mar.-Apr. 1998, pp. 337-344.;;Torii T. et al., Shear slowness evaluation by parametric inversion of dipole waveforms, 2016 SEG International Exposition and 86th Annual Meeting, pp. 637-641.;;Scheibner D. et al., 2010, Slow formation shear from an LWD tool: quadrupole inversion with a gulf of mexico example, SPWLA 51st Annual Logging Symposium, Jun. 2010, 14 pages.;;Hsu K. and Chang S.K., 1985, Multiple shot processing of array sonic waveforms for high resolution sonic logs, SEG Conference, Borehole Geophysics II, BHG 2.4, pp. 42-44.;;Yu G. and Mallat S., 2008, Audio denoising by time-frequency block thresholding, IEEE Transactions on Signal processing, vol. 56, No. 5, May 2008, pp. 1830-1839.;;International Search Report and Written Opinion for the equivalent PCT Application PCT/US2019/053937 dated Jan. 17, 2020, 10 pages.;;International Preliminary Report on Patentability of International Patent Application No. PCT/US2019/053937 dated Apr. 15, 2021, 7 pages.;;Extended Search Report issued in European Patent Application No. 19869093.5 dated May 17, 2022, 6 pages.;;Exam Report issued in European Patent Application No. 19869093.5 dated Aug. 18, 2023, 5 pages.",ACTIVE
32,MX,A,MX 2021003883 A,015-339-178-999-227,2021-09-08,2021,MX 2021003883 A,2019-10-01,US 201862739580 P;;US 2019/0053937 W,2018-10-01,METHOD AND DEVICE FOR DETERMINING SONIC SLOWNESS.,"Sonic logging data including a sonic waveform associated with a plurality of shot gathers is accessed. A transformation operator is applied to the sonic logging data to provide a transformed sonic image, the transformation operator including at least one of a short time average long time average (STA/LTA) operator, a phase shift operator, and a deconvolution operator. A machine learning process is performed using the transformed sonic image to determine a sonic slowness associated with the sonic logging data. The sonic slowness is provided as an output.",GEOQUEST SYSTEMS BV,YAMAMOTO HIROAKI;;AKKURT RIDVAN;;KHADHRAOUI BASSEM;;LAM LU DUC DUONG;;WIELEMAKER ERIK;;KISRA SAAD,,https://lens.org/015-339-178-999-227,Patent Application,no,0,0,8,8,0,G01V1/50;;G01V1/42;;G01V2210/6222;;G01V1/303;;G06N3/08;;G06N3/045;;G01V1/303;;G01V1/345;;G01V2210/6222;;G06N3/04,G01V1/48;;E21B41/00;;E21B47/00;;G01V1/50;;G06N20/00,,0,0,,,,PENDING
33,CN,A,CN 112888970 A,196-291-991-227-426,2021-06-01,2021,CN 201980069118 A,2019-10-01,US 201862739580 P;;US 2019/0053937 W,2018-10-01,METHOD AND DEVICE FOR DETERMINING SONIC SLOWNESS,"Sonic logging data including a sonic waveform associated with a plurality of shot gathers is accessed. A transformation operator is applied to the sonic logging data to provide a transformed sonic image, the transformation operator including at least one of a short time average long time average (STA/LTA) operator, a phase shift operator, and a deconvolution operator. A machine learning process is performed using the transformed sonic image to determine a sonic slowness associated with the sonic logging data. The sonic slowness is provided as an output.",GEOQUEST SYSTEMS BV,KHADHRAOUI BASSEM;;LAM LU DUC DUONG;;AKKURT RIDVAN;;YAMAMOTO HIROAKI;;WIELEMAKER ERIK;;KISRA SAAD,,https://lens.org/196-291-991-227-426,Patent Application,no,9,0,8,8,0,G01V1/50;;G01V1/42;;G01V2210/6222;;G01V1/303;;G06N3/08;;G06N3/045;;G01V1/303;;G01V1/345;;G01V2210/6222;;G06N3/04,G01V1/48;;E21B41/00;;E21B47/00;;G01V1/50;;G06N20/00,,0,0,,,,PENDING
34,EP,A1,EP 3861378 A1,075-759-841-913-248,2021-08-11,2021,EP 19869093 A,2019-10-01,US 201862739580 P;;US 2019/0053937 W,2018-10-01,METHOD AND DEVICE FOR DETERMINING SONIC SLOWNESS,,SERVICES PETROLIERS SCHLUMBERGER;;GEOQUEST SYSTEMS BV,KHADHRAOUI BASSEM;;LAM LU DUC DUONG;;AKKURT RIDVAN;;YAMAMOTO HIROAKI;;WIELEMAKER ERIK;;KISRA SAAD,,https://lens.org/075-759-841-913-248,Patent Application,yes,0,0,8,8,0,G01V1/50;;G01V1/42;;G01V2210/6222;;G01V1/303;;G06N3/08;;G06N3/045;;G01V1/303;;G01V1/345;;G01V2210/6222;;G06N3/04,E21B41/00;;G01V1/48;;E21B47/00;;G01V1/50;;G06N20/00,,0,0,,,,PENDING
35,AU,A1,AU 2019/351822 A1,087-747-710-649-296,2021-05-13,2021,AU 2019/351822 A,2019-10-01,US 201862739580 P;;US 2019/0053937 W,2018-10-01,Method and device for determining sonic slowness,"Sonic logging data including a sonic waveform associated with a plurality of shot gathers is accessed. A transformation operator is applied to the sonic logging data to provide a transformed sonic image, the transformation operator including at least one of a short time average long time average (STA/LTA) operator, a phase shift operator, and a deconvolution operator. A machine learning process is performed using the transformed sonic image to determine a sonic slowness associated with the sonic logging data. The sonic slowness is provided as an output.",GEOQUEST SYSTEMS BV,KHADHRAOUI BASSEM;;LAM LU DUC DUONG;;AKKURT RIDVAN;;YAMAMOTO HIROAKI;;WIELEMAKER ERIK;;KISRA SAAD,,https://lens.org/087-747-710-649-296,Patent Application,no,0,0,8,8,0,G01V1/50;;G01V1/42;;G01V2210/6222;;G01V1/303;;G06N3/08;;G06N3/045;;G01V1/303;;G01V1/345;;G01V2210/6222;;G06N3/04,G01V1/48;;E21B41/00;;E21B47/00;;G01V1/50;;G06N20/00,,0,0,,,,PENDING
36,EP,A4,EP 3861378 A4,096-723-484-353-285,2022-06-15,2022,EP 19869093 A,2019-10-01,US 201862739580 P;;US 2019/0053937 W,2018-10-01,METHOD AND DEVICE FOR DETERMINING SONIC SLOWNESS,,SERVICES PETROLIERS SCHLUMBERGER;;GEOQUEST SYSTEMS BV,KHADHRAOUI BASSEM;;LAM LU DUC DUONG;;AKKURT RIDVAN;;YAMAMOTO HIROAKI;;WIELEMAKER ERIK;;KISRA SAAD,,https://lens.org/096-723-484-353-285,Search Report,no,4,0,8,8,0,G01V1/50;;G01V1/42;;G01V2210/6222;;G01V1/303;;G06N3/08;;G06N3/045;;G01V1/303;;G01V1/345;;G01V2210/6222;;G06N3/04,G01V1/48;;E21B41/00;;E21B47/00;;G01V1/50;;G06N20/00,,1,0,,,See also references of WO 2020072404A1,PENDING
37,US,A1,US 2022/0018983 A1,125-129-605-077-386,2022-01-20,2022,US 201917250941 A,2019-10-01,US 201917250941 A;;US 201862739580 P;;US 2019/0053937 W,2018-10-01,METHOD AND DEVICE FOR DETERMINING SONIC SLOWNESS,"Sonic logging data including a sonic waveform associated with a plurality of shot gathers is accessed. A transformation operator is applied to the sonic logging data to provide a transformed sonic image, the transformation operator including at least one of a short time average long time average (STA/LTA) operator, a phase shift operator, and a deconvolution operator. A machine learning process is performed using the transformed sonic image to determine a sonic slowness associated with the sonic logging data. The sonic slowness is provided as an output.",SCHLUMBERGER TECHNOLOGY CORP,KHADHRAOUI BASSEM;;LAM LU DUC DUONG;;AKKURT RIDVAN;;YAMAMOTO HIROAKI;;WIELEMAKER ERIK;;KISRA SAAD,SCHLUMBERGER TECHNOLOGY CORPORATION (2019-11-01),https://lens.org/125-129-605-077-386,Patent Application,yes,4,0,8,8,0,G01V1/50;;G01V1/42;;G01V2210/6222;;G01V1/303;;G06N3/08;;G06N3/045;;G01V1/303;;G01V1/345;;G01V2210/6222;;G06N3/04,G01V1/30;;G01V1/34;;G06N3/04,,0,0,,,,ACTIVE
38,US,B1,US 11890960 B1,092-838-063-881-72X,2024-02-06,2024,US 202318183193 A,2023-03-14,US 202318183193 A;;US 202263477722 P,2022-12-29,Interface based electrical load management,"Configuring chargers at a charging site is provided. A data processing system can include a processor coupled with memory and configured to identify a configuration. The configuration can indicate a plurality of chargers coupled with a first line of an electrical panel to conduct power at a first phase and a second line of the electrical panel to conduct power at a second phase different than the first phase. The one or more processors can cause, based on the configuration and operational characteristics associated with one or more of the plurality of chargers, a controller to deliver power to a charger of the plurality of chargers via the first line and the second line based on the power capacity of the electrical panel.",RIVIAN IP HOLDINGS LLC,BHATI JAIVARDHAN S;;MA LINGXIAO;;LEE SIQING;;ZHOU CECILIA AN;;CAO YIXIN;;DUONG BRYAN DUC,RIVIAN AUTOMOTIVE LLC (2023-03-10);;RIVIAN IP HOLDINGS LLC (2023-03-10),https://lens.org/092-838-063-881-72X,Granted Patent,yes,7,0,1,1,0,B60L53/67;;G05B2219/2639;;G05B19/042;;B60L53/63,B60L53/67;;B60L53/63;;G05B19/042,,0,0,,,,ACTIVE
39,SG,A1,SG 183140 A1,127-395-561-626-607,2012-09-27,2012,SG 2012057337 A,2011-02-02,US 30183010 P;;SG 2011000049 W,2010-02-05,OCCLUSION DEVICE FOR CLOSING ANATOMICAL DEFECTS,"The present invention generally relates to the field of transcatheter device closure techniques for closing an opening in a tissue and more particularly, to occlusion devices for closing anatomical defects in tissue. More particularly the present invention refers to occlusion devices for closing septal abnormalities such as atrial septal defects and patent foramen ovale, and to methods of closing an anatomical defect in a tissue.",UNIV NANYANG TECH,SUBRAMANIAN VENKATRAMAN;;BOEY YIN CHIANG FREDDY;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,,https://lens.org/127-395-561-626-607,Patent Application,no,0,0,4,4,0,A61B17/0057;;A61B17/0057;;A61B2017/00575;;A61B2017/00575;;A61B2017/00597;;A61B2017/00597;;A61B2017/00606;;A61B2017/00606;;A61B2017/00615;;A61B2017/00615;;A61B2017/00619;;A61B2017/00619;;A61B2017/00623;;A61B2017/00623,,,0,0,,,,PENDING
40,US,A1,US 2013/0030455 A1,167-022-829-866-513,2013-01-31,2013,US 201113576927 A,2011-02-02,US 201113576927 A;;US 30183010 P;;SG 2011000049 W,2010-02-05,OCCLUSION DEVICE FOR CLOSING ANATOMICAL DEFECTS,"The present invention generally relates to the field of transcatheter device closure techniques for closing an opening in a tissue and more particularly, to occlusion devices for closing anatomical defects in tissue. More particularly the present invention refers to occlusion devices for closing septal abnormalities such as atrial septal defects and patent foramen ovale, and to methods of closing an anatomical defect in a tissue.",UNIV NANYANG TECH;;SUBRAMANIAN VENKATRAMAN;;BOEY YIN CHIANG FREDDY;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,SUBRAMANIAN VENKATRAMAN;;BOEY YIN CHIANG FREDDY;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,NANYANG TECHNOLOGICAL UNIVERSITY (2012-09-04),https://lens.org/167-022-829-866-513,Patent Application,yes,22,5,4,4,0,A61B17/0057;;A61B17/0057;;A61B2017/00575;;A61B2017/00575;;A61B2017/00597;;A61B2017/00597;;A61B2017/00606;;A61B2017/00606;;A61B2017/00615;;A61B2017/00615;;A61B2017/00619;;A61B2017/00619;;A61B2017/00623;;A61B2017/00623,A61B17/03,606/157,0,0,,,,ACTIVE
41,WO,A2,WO 2010/028087 A2,028-160-399-263-602,2010-03-11,2010,US 2009/0055784 W,2009-09-02,US 9370108 P,2008-09-02,NANOPARTICLE-STEM CELL CONJUGATES FOR POST-INFARCTION TREATMENT,"The present invention relates to constructs comprising living cells, preferably stem cells, which have been coated with one or more layers of polyelectrolytes of alternating charge and to the outermost layer of which is electrostatically conjugated nanoparticles that carry one or more therapeutic agents. The invention further relates to the use of the constructs to treat myocardial infarction.",ABBOTT CARDIOVASCULAR SYSTEMS;;HENG BOON CHIN ALEXIS;;BASU SHUBHAYU;;COWAN CATHERINE M;;DAVALIAN DARIUSH;;STANKUS JOHN;;DUONG DUC H,HENG BOON CHIN ALEXIS;;BASU SHUBHAYU;;COWAN CATHERINE M;;DAVALIAN DARIUSH;;STANKUS JOHN;;DUONG DUC H,,https://lens.org/028-160-399-263-602,Patent Application,yes,0,8,17,17,0,A61M25/0052;;A61M25/0054;;A61M2025/0089;;A61P9/00;;A61P9/10;;A61M25/0054;;A61M2025/0089;;A61M25/0052,A61L27/38;;A61F2/02;;A61F2/82;;A61L27/28;;A61L27/34;;A61L27/54,,0,0,,,,PENDING
42,EP,A2,EP 2331154 A2,060-067-617-098-742,2011-06-15,2011,EP 09812185 A,2009-09-02,US 2009/0055784 W;;US 9370108 P,2008-09-02,NANOPARTICLE-STEM CELL CONJUGATES FOR POST-INFARCTION TREATMENT,,ABBOTT CARDIOVASCULAR SYSTEMS,HENG BOON CHIN ALEXIS;;BASU SHUBHAYU;;COWAN CATHERINE M;;DAVALIAN DARIUSH;;STANKUS JOHN;;DUONG DUC H,,https://lens.org/060-067-617-098-742,Patent Application,yes,0,0,17,17,0,A61M25/0052;;A61M25/0054;;A61M2025/0089;;A61P9/00;;A61P9/10;;A61M25/0054;;A61M2025/0089;;A61M25/0052,A61M25/00,,0,0,,,,DISCONTINUED
43,WO,A1,WO 2011/096896 A1,018-436-675-663-330,2011-08-11,2011,SG 2011000049 W,2011-02-02,US 30183010 P,2010-02-05,OCCLUSION DEVICE FOR CLOSING ANATOMICAL DEFECTS,"The present invention generally relates to the field of transcatheter device closure techniques for closing an opening in a tissue and more particularly, to occlusion devices for closing anatomical defects in tissue. More particularly the present invention refers to occlusion devices for closing septal abnormalities such as atrial septal defects and patent foramen ovale, and to methods of closing an anatomical defect in a tissue.",UNIV NANYANG TECH;;SUBRAMANIAN VENKATRAMAN;;BOEY YIN CHIANG FREDDY;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,SUBRAMANIAN VENKATRAMAN;;BOEY YIN CHIANG FREDDY;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,,https://lens.org/018-436-675-663-330,Patent Application,yes,6,7,4,4,0,A61B17/0057;;A61B17/0057;;A61B2017/00575;;A61B2017/00575;;A61B2017/00597;;A61B2017/00597;;A61B2017/00606;;A61B2017/00606;;A61B2017/00615;;A61B2017/00615;;A61B2017/00619;;A61B2017/00619;;A61B2017/00623;;A61B2017/00623,A61B17/03;;A61B17/00,,0,0,,,,PENDING
44,WO,A3,WO 2010/028087 A3,025-480-727-199-448,2010-05-14,2010,US 2009/0055784 W,2009-09-02,US 9370108 P,2008-09-02,NANOPARTICLE-STEM CELL CONJUGATES FOR POST-INFARCTION TREATMENT,"The present invention relates to constructs comprising living cells, preferably stem cells, which have been coated with one or more layers of polyelectrolytes of alternating charge and to the outermost layer of which is electrostatically conjugated nanoparticles that carry one or more therapeutic agents. The invention further relates to the use of the constructs to treat myocardial infarction.",ABBOTT CARDIOVASCULAR SYSTEMS;;HENG BOON CHIN ALEXIS;;BASU SHUBHAYU;;COWAN CATHERINE M;;DAVALIAN DARIUSH;;STANKUS JOHN;;DUONG DUC H,HENG BOON CHIN ALEXIS;;BASU SHUBHAYU;;COWAN CATHERINE M;;DAVALIAN DARIUSH;;STANKUS JOHN;;DUONG DUC H,,https://lens.org/025-480-727-199-448,Search Report,yes,3,0,17,17,0,A61M25/0052;;A61M25/0054;;A61M2025/0089;;A61P9/00;;A61P9/10;;A61M25/0054;;A61M2025/0089;;A61M25/0052,A61L27/38;;A61F2/02;;A61F2/82;;A61L27/28;;A61L27/34;;A61L27/54,,2,2,068-054-627-081-117;;009-623-601-409-29X,10.1002/mabi.200700061;;17599337;;10.1016/j.biomaterials.2006.07.037;;16919722,"VEERABADRAN ET AL.: ""Nanoencapsulation of Stem Cells within Polyelectrolyte M ultilayer Shells"", MACROMOLECULAR BIOSCIENCE, vol. 7, 2007, pages 877 - 882, XP008145274;;EVELYN K.F.YIM ET AL.: ""Proliferation and differentiation of human mesenchyma 1 stem cell encapsulated in polyelectrolyte complexation fibrous scaffold"", BIOMATERIALS, vol. 27, 2006, pages 6111 - 6122, XP025097004",PENDING
45,US,B2,US 9295456 B2,035-123-444-045-219,2016-03-29,2016,US 201113576927 A,2011-02-02,US 201113576927 A;;US 30183010 P;;SG 2011000049 W,2010-02-05,Occlusion device for closing anatomical defects,"The present invention generally relates to the field of transcatheter device closure techniques for closing an opening in a tissue and more particularly, to occlusion devices for closing anatomical defects in tissue. More particularly the present invention refers to occlusion devices for closing septal abnormalities such as atrial septal defects and patent foramen ovale, and to methods of closing an anatomical defect in a tissue.",SUBRAMANIAN VENKATRAMAN;;BOEY YIN CHIANG FREDDY;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC;;UNIV NANYANG TECH,SUBRAMANIAN VENKATRAMAN;;BOEY YIN CHIANG FREDDY;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,NANYANG TECHNOLOGICAL UNIVERSITY (2012-09-04),https://lens.org/035-123-444-045-219,Granted Patent,yes,29,11,4,4,0,A61B17/0057;;A61B17/0057;;A61B2017/00575;;A61B2017/00575;;A61B2017/00597;;A61B2017/00597;;A61B2017/00606;;A61B2017/00606;;A61B2017/00615;;A61B2017/00615;;A61B2017/00619;;A61B2017/00619;;A61B2017/00623;;A61B2017/00623,A61B17/08;;A61B17/00,,0,0,,,,ACTIVE
46,EP,A4,EP 2331154 A4,038-054-023-653-526,2014-10-22,2014,EP 09812185 A,2009-09-02,US 2009/0055784 W;;US 9370108 P,2008-09-02,NANOPARTICLE-STEM CELL CONJUGATES FOR POST-INFARCTION TREATMENT,,ABBOTT CARDIOVASCULAR SYSTEMS,HENG BOON CHIN ALEXIS;;BASU SHUBHAYU;;COWAN CATHERINE M;;DAVALIAN DARIUSH;;STANKUS JOHN;;DUONG DUC H,,https://lens.org/038-054-023-653-526,Search Report,no,0,0,17,17,0,A61M25/0052;;A61M25/0054;;A61M2025/0089;;A61P9/00;;A61P9/10;;A61M25/0054;;A61M2025/0089;;A61M25/0052,A61M25/00,,3,3,094-517-973-384-007;;103-151-182-764-952;;016-327-527-030-325,10.1002/term.160;;19283725;;10.1016/j.bios.2005.07.011;;16099641;;10.1016/j.biomaterials.2003.10.033;;15020132,"BOON C. HENG ET AL: ""Electrostatic binding of nanoparticles to mesenchymal stem cells via high molecular weight polyelectrolyte chains"", JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, vol. 3, no. 4, 1 June 2009 (2009-06-01), pages 243 - 254, XP055139644, ISSN: 1932-6254, DOI: 10.1002/term.160;;GERMAIN M ET AL: ""Protection of mammalian cell used in biosensors by coating with a polyelectrolyte shell"", BIOSENSORS AND BIOELECTRONICS, ELSEVIER BV, NL, vol. 21, no. 8, 15 February 2006 (2006-02-15), pages 1566 - 1573, XP024961448, ISSN: 0956-5663, [retrieved on 20060215], DOI: 10.1016/J.BIOS.2005.07.011;;KHADEMHOSSEINI A ET AL: ""Layer-by-layer deposition of hyaluronic acid and poly-l-lysine for patterned cell co-cultures"", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 25, no. 17, 1 August 2004 (2004-08-01), pages 3583 - 3592, XP004496085, ISSN: 0142-9612, DOI: 10.1016/J.BIOMATERIALS.2003.10.033",DISCONTINUED
47,US,B2,US 10905405 B2,066-647-317-588-829,2021-02-02,2021,US 201013516065 A,2010-12-17,US 201013516065 A;;US 28754409 P;;SG 2010000476 W,2009-12-17,Occlusion device for closing anatomical defects,"The present invention generally relates to the field of transcatheter device closure techniques for closing an opening in a tissue and more particularly, to occlusion devices for closing anatomical defects in tissue such as defects consisting of an opening connecting a front side and a back side of a tissue. More particularly the present invention relates to occlusion devices for closing septal abnormalities such as atrial septal defects and patent foramen ovale, delivering systems for such occlusion devices, kits comprising the occlusion devices and the delivering systems and to methods of closing an anatomical defect in a tissue consisting of an opening connecting a front side and a back side of a tissue.",VENKATRAMAN SUBRAMANIAN;;BOEY YIN CHIANG FREDDY;;WU WEI;;TANG YONG DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC;;UNIV NANYANG TECH,VENKATRAMAN SUBRAMANIAN;;BOEY YIN CHIANG FREDDY;;WU WEI;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,NANYANG TECHNOLOGICAL UNIVERSITY (2012-07-19),https://lens.org/066-647-317-588-829,Granted Patent,yes,25,0,8,8,0,A61B17/0057;;A61B17/0057;;A61B2017/00243;;A61B2017/00243;;A61B2017/00592;;A61B2017/00592;;A61B2017/00597;;A61B2017/00597;;A61B2017/00606;;A61B2017/00606;;A61B2017/00619;;A61B2017/00619;;A61B2017/00623;;A61B2017/00623;;A61B2090/3966;;A61B2090/3966,A61B17/00;;A61B90/00,,55,46,078-489-533-457-510;;016-398-123-380-597;;080-762-966-762-859;;020-111-034-931-936;;034-432-817-068-767;;027-542-815-489-959;;105-748-182-987-325;;085-384-902-409-649;;127-360-599-294-548;;038-850-330-144-710;;004-341-568-251-007;;012-528-133-866-221;;135-080-977-351-639;;143-373-574-403-763;;017-835-803-545-884;;021-838-790-841-139;;019-347-196-271-139;;108-767-936-203-738;;010-521-770-502-864;;056-678-903-571-607;;031-687-728-467-315;;021-080-625-894-409;;108-359-992-433-834;;004-140-879-536-404;;148-313-873-480-758;;113-634-059-303-244;;062-496-419-599-00X;;127-580-312-579-074;;036-000-366-607-584;;030-111-021-842-216;;050-824-358-980-716;;131-194-838-168-674;;038-546-611-708-053;;034-971-619-671-816;;127-333-872-048-062;;015-277-860-890-143;;010-950-384-349-502;;097-508-837-459-523;;140-426-043-874-053;;063-229-803-037-511;;020-333-379-372-002;;027-059-741-880-68X;;014-844-607-101-480;;019-498-693-942-122;;057-464-284-246-110;;026-564-271-419-098,10.1161/circulationaha.106.664672;;17062781;;10.1016/j.mri.2005.10.010;;16376188;;18288745;;10.1002/ccd.21383;;15226215;;10.1161/01.cir.0000135471.17922.17;;10.1016/j.jacc.2005.10.044;;16412874;;17333641;;10.3949/ccjm.74.2.137;;17395315;;10.1016/j.ijcard.2006.12.028;;10.1016/s0735-1097(01)01427-9;;11527606;;18802796;;10.1056/nejmoa011503;;11742048;;18822432;;10.1016/j.jns.2008.08.018;;19021283;;10.1002/ccd.21876;;9506341;;10.1016/s0002-8703(98)70332-1;;10.1161/01.cir.0000017498.88393.44;;12045168;;10.7326/0003-4819-139-9-200311040-00010;;14597460;;10.1161/01.str.28.12.2376;;9412617;;10567299;;10.1016/j.acvd.2008.05.020;;18848685;;19047442;;10.1136/hrt.2007.121038;;10.1111/j.1445-5994.2005.00948.x;;16313545;;18953276;;pmc1768045;;14729794;;10.1136/hrt.2002.003111;;18324695;;10.1002/ccd.21458;;10.1016/s0735-1097(04)91593-8;;16814662;;10.1016/j.jacc.2006.02.057;;10.1016/j.jacc.2003.10.030;;14736453;;10.1017/s1047951100008210;;11049128;;15120830;;10.1016/j.jacc.2003.12.042;;15585232;;10.1016/j.biomaterials.2004.07.052;;10.1021/ma010067m;;10.1021/ma0513259;;10.1016/s0032-3861(01)00217-8;;10.1016/s0141-3910(00)00031-8;;10.1016/j.polymer.2004.10.054;;10.1002/(sici)1097-4628(19960222)59:8<1281::aid-app11>3.0.co;2-9;;10.1002/(sici)1097-4636(19981215)42:4<475::aid-jbm1>3.0.co;2-b;;9827669;;10.1016/s0142-9612(97)00080-x;;10403042;;10.1002/(sici)1097-4628(20000214)75:7<874::aid-app3>3.0.co;2-g;;10.1023/a:1008962719355;;15347936;;10.1007/s00289-006-0680-6;;6792722;;10.1089/ten.2006.12.449;;16579678;;15363505;;10.1016/j.ijpharm.2004.06.022;;10.1002/app.10483;;12322987;;10.1016/s0142-9612(02)00215-6;;10.1016/s0142-9612(97)00106-3;;9613812,"Synonym: fold; http://www.thesaurus.com/browse/fold; Mar. 10, 2016.;;Amplatzer™ Septal Occluder; Structural Heart Therapy; St. Jude Medical; Downloaded at http://www.sjmprofessional.com/Products/Intl/structural-heart-therapy/amplatzer-sept . . . on Apr. 9, 2012.;;Mullen Michael J., et al.; BioSTAR Evaluation Study (BEST); A Prospective, Multicenter, Phase I Clinical Trial to Evaluate the Feasibility, Efficacy, and Safety of the BioSTAR Bioabsorbable Septal Repair Implant for the Closure of the Atrial-Level Shunts; 2006 American Heart Association; pp. 1962-1967.;;Shellock, Frank G., et al; Septal Repair Implants: evaluation of magnetic resonance imaging safety at 3 T; Magnetic Resonance Imaging 23 (2005) 1021-1025.;;Gore® Helex Septal Occluder; Leave Behind the Best; Performance by Design; Aug. 2010.;;Spies, Christine, et al.; Patent Foramen Ovale Closure with the Intrasept Occluder: Complete 6-56 Months Follow-Up of 247 Patients After Presumed Paradoxical Embolism; Catheterization and Cardiovascular Interventions 71:390-395 (2008).;;Premere™ PFO Closure System; Structural Heart Therapy; St. Jude Medical; Downloaded at http://www.sjmprofessional.com/Products/Intl/structural-heart-therapy/premere-pfo-cl . . . on Apr. 9, 2012.;;Daehnert, Ingo & Gielen, Stephen; Congenital & Structural Interventions; PFO-Closure with the Solysafe Occluder (Leipzig Experience); Herzzentrum, University of Leipzig; Leipzig, Germany; Jul. 9-11, 2009.;;Marshall A C, van der Velde M E, Tworetzky W, et al.; Creation of an atrial septal defect in utero for fetuses with hypoplastic left heart syndrome and intact or highly restrictive atrial septum; Circulation 2004;110(3):253-58.;;Meissner I, Khandheria B K, Heit J A, et al.; Patent foramen ovale: Innocent or guilty? Evidence from a prospective population-based study. Journal of the American College of Cardiology 2006;47(2):440-45.;;Krasuski R A.; When and how to fix a ‘hole in the heart’: Approach to ASD and PFO. Cleveland Clinic Journal of Medicine 2007;74(2):137-47.;;Drighil A, El Mosalami H, Elbadaoui N, et al.; Patent foramen ovale: A new disease? International Journal of Cardiology 2007;122(1):1-9.;;Kerut E K, Norfleet W T, Plotnick G D, et al.; Patent foramen ovale: A review of associated conditions and the impact of physiological size. Journal of the American College of Cardiology 2001;38(3):613-23.;;Cuadrado M L, Pareia J A.; Patent foramen ovale and migraine: where is the connection? Neurologia 2008;23(8):475-83.;;Mas J L, Arquizan C, Lamy C, et al.; Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. New England Journal of Medicine 2001;345(24):1740-46.;;Ozdemir A O, Tamayo A, Munoz C, et al.; Cryptogenic stroke and patent foramen ovale: Clinical clues to paradoxical embolism. Journal of the Neurological Sciences 2008;275(1-2):121-27.;;Meier B.; Paradoxical embolism through the patent foramen ovale—the elderly is where the money is. Catheterization and Cardiovascular Interventions 2008;72(7):971-72.;;Nendaz M R, Sarasin F P, Junod A F, et al.; Preventing stroke recurrence in patients with patent foramen ovale: Antithrombotic therapy, foramen closure, or therapeutic abstention? A decision analytic perspective. American Heart Journal 1998;135(3):532-41.;;Homma S, Sacco R L, Di Tullio M R, et al.; Effect of medical treatment in stroke patients with patent foramen ovale—Patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002;105(22):2625-31.;;Khairy P, O'Donnell C P, Landzberg M J.; Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli—A systematic review. Annals of Internal Medicine 2003;139(9):753-60.;;Homma S, DiTullio M R, Sacco R L, et al.; Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997;28(12):2376-81.;;Dearani J A, Ugurlu B S, Danielson G K, et al.; Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999;100(19):171-75.;;Van de Wyngaert F, Kefer J, Hermans C, et al.; Absence of recurrent stroke after percutaneous closure of patent foramen ovale despite residual right-to-left cardiac shunt assessed by transcranial Doppler. Archives of Cardiovascular Diseases 2008;101(7-8):435-41.;;Wahl A, Meier B.; Patent foramen ovale and ventricular septal defect closure. Heart 2009;95(1):70-82.;;Bijl J M, Ruygrok P N, Hornung T S, et al.; Percutaneous closure of patent foramen ovale. Internal Medicine Journal 2005;35(12):706-10.;;Kedia G, Tobis J, Lee M S.; Patent foramen ovale: Clinical manifestations and treatment. Reviews in Cardiovascular Medicine 2008;9(3):168-73.;;Schwerzmann M, Windecker S, Wahl A, et al.; Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart 2004;90(2):186-90.;;Luermans J, Post M C, Schrader R, et al. ; Outcome after percutaneous closure of a patent foramen ovale using the Intrasept (TM) device: A multi-centre study. Catheterization and Cardiovascular Interventions 2008;71(6):822-28.;;Sorensen S G, Casterella P J, Muhlestein J B, et al.; Reduced adverse event rates after transcatheter closure of patent foramen ovale when using the Amplatzer-PFO (TM) compared to the CardioSeal (TM) device. 54th Annual Scientific Session of the American-College-of-Cardiology, New Orleans, LA, 2004. p. 377A-77A.;;Hein R, Bayard Y, Taaffe M, et al.; Patent foramen ovale and left atrial appendage: New devices and methods for closure. 8th Pediatric Interventional Cardiac Symposium (PICS-VIII)/2nd Conference on Emerging New Technologies in Congenital Heart Surgery (ENTICHS-II), Chicago, IL, 2005. p. 234-40.;;Jux C, Bertram H, Wohlsein P, et al.; Interventional atrial septal defect closure using a totally bioresorbable occluder matrix—Development and preclinical evaluation of the BioSTAR device. Journal of the American College of Cardiology 2006;48(1);161-69.;;Krumsdorf U, Ostermayer S, Billinger K, et al.; Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. Journal of the American College of Cardiology 2004;43(2):302-09.;;Carminati M, Giusti S, Hausdorf G, et al.; A European multicentric experience using the CardioSEAL((R)) and Starflex double umbrella devices to close interatrial communications holes within the oval fossa. Cardiology in the Young 2000;10(5):519-26.;;Suda K, Raboisson M J, Piette E, et al.; Reversible atrioventricular block associated with closure of atrial septal defects using the amplatzer device. Journal of the American College of Cardiology 2004;43(9):1677-82.;;Cohn D, Salomon A F.; Designing biodegradable multiblock PCL/PLA thermoplastic elastomers. Biomaterials 2005;26(15):2297-305.;;Tasaka F, Ohya Y, Ouchi T.; Synthesis of novel comb-type polylactide and its biodegradability. Macromolecules 2001;34(16):5494-500.;;Gottschalk C, Frey H.; Hyperbranched polylactide copolymers. Macromolecules 2006;39(5):1719-23.;;Kim J K, Park D J, Lee M S, et al.; Synthesis and crystallization behavior of poly(L-lactide)-block-poly(epsilon-caprolactone) copolymer. Polymer 2001;42(17):7429-41.;;Qian H T, Bei J Z, Wang S G.; Synthesis, characterization and degradation of ABA block copoiymer of L-lactide and epsilon-caprolactone. Polymer Degradation and Stability 2000;68(3):423-29.;;Huang M H, Li S M, Vert M.; Synthesis and degradation of PLA-PCL-PLA triblock copolymer prepared by successive polymerization of epsilon-caprolactone and (DL)-lactide. Polymer 2004;45(26):8675-81.;;HiljanenVainio M, Karjalainen T, Seppala J.; Biodegradable lactone copolymers .1. Characterization and mechanical behavior of epsilon-caprolactone and lactide copolymers. Journal of Applied Polymer Science 1996;59(8):1281-88.;;Nakamura T, Shimizu Y, Takimoto Y, et al.; Biodegradation and tumorigenicity of implanted plates made from a copolymer of epsilon-caprolactone and L-lactide in rat. Journal of Biomedical Materials Research 1998;42(4):475-84.;;Ekholm M, Hietanen J, Lindqvist C, et al.; Histological study of tissue reactions to epsilon-caprolactone-lactide copolymer in paste form. Biomaterials 1999;20(14):1257-62.;;Ge H X, Hu Y, Yang S C, et al.; Preparation, characterization, and drug release behaviors of drug-loaded epsilon-caprolactone/L-lactide copolymer nanoparticles. Journal of Applied Polymer Science 2000;75(7):874-82.;;Sailynoja E, Koskinen M, Salonen J, et al.; Immobilization of a biologically active coating on a hydrophobic L-lactide-epsilon-caprolactone copolymer. Journal of Materials Science—Materials in Medicine 1999;10(12):703-05.;;Lu X L, Cai W, Gao Z Y, et al.; Shape memory effects of poly(L-lactide) and its copolymer with poly(epsilon-caprolactone). Polymer Bulletin 2007;58(2):381-91.;;Ray J A, Doddi N, Regula D, et al.; Polydioxanone (PDS), A Novel Mono-Filament Synthetic Absorbable Suture. Surgery Gynecology & Obstetrics 1981;153(4):497-507.;;Xie J, Ihara M, Jung Y M, et al.; Mechano-active scaffold design based on microporous poly(L-lactide-co-epsilon-caprolactone) for articular cartilage tissue engineering: Dependence of porosity on compression force-applied mechanical behaviors. Tissue Engineering 2006;12(3):449-58.;;Tan L P, Venkatraman S S, Sung P F, et al.; Effect of plasticization on heparin release from biodegradable matrices. International Journal of Pharmaceutics 2004;283(1-2):89-96.;;Xie Y C, Yang Q F.; Surface modification of poly(vinyl chloride) for antithrombogenicity study. Journal of Applied Polymer Science 2002;85(5):1013-18.;;Yang M C, Lin W C.; Surface modification and blood compatibility of polyacrylonitrile membrane with immobilized chitosan-heparin conjugate. Journal of Polymer Research-Taiwan 2002;9(3):201-06.;;Zhu A P, Zhang M, Wu J, et al.; Covalent immobilization of chitosan/heparin complex with a photosensitive hetero-bifunctional crosslinking reagent on PLA surface. Biomaterials 2002;23(23):4657-65.;;Kreitz M R, Domm J A, Mathiowitz E.; Controlled delivery of therapeutics from microporous membranes. II. In vitro degradation and release of heparin-loaded poly(D,L-lactide-co-glycolide). Biomaterials 1997;18(24):1645-51.;;International Preliminary Report on Patentability and Written Opinion for Application No. PCT/SG2010/000476 dated Jun. 19, 2012.;;International Search Report for Application No. PCT/SG2010/000476 dated Apr. 5, 2011.",ACTIVE
48,SG,A1,SG 181658 A1,194-541-420-609-662,2012-07-30,2012,SG 2012043238 A,2010-12-17,US 28754409 P;;SG 2010000476 W,2009-12-17,OCCLUSION DEVICE FOR CLOSING ANATOMICAL DEFECTS,"The present invention generally relates to the field of transcatheter device closure techniques for closing an opening in a tissue and more particularly, to occlusion devices for closing anatomical defects in tissue such as defects consisting of an opening connecting a front side and a back side of a tissue. More particularly the present invention relates to occlusion devices for closing septal abnormalities such as atrial septal defects and patent foramen ovale, delivering systems for such occlusion devices, kits comprising the occlusion devices and the delivering systems and to methods of closing an anatomical defect in a tissue consisting of an opening connecting a front side and a back side of a tissue.",UNIV NANYANG TECH,VENKATRAMAN SUBRAMANIAN;;BOEY YIN CHIANG FREDDY;;WU WEI;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,,https://lens.org/194-541-420-609-662,Patent Application,no,0,0,8,8,0,A61B17/0057;;A61B17/0057;;A61B2017/00243;;A61B2017/00243;;A61B2017/00592;;A61B2017/00592;;A61B2017/00597;;A61B2017/00597;;A61B2017/00606;;A61B2017/00606;;A61B2017/00619;;A61B2017/00619;;A61B2017/00623;;A61B2017/00623;;A61B2090/3966;;A61B2090/3966,,,0,0,,,,PENDING
49,SG,A1,SG 192410 A1,099-450-033-019-745,2013-08-30,2013,SG 2013046347 A,2010-12-17,US 28754409 P,2009-12-17,OCCLUSION DEVICE FOR CLOSING ANATOMICAL DEFECTS,"The present invention generally relates to the field of transcatheter device closure techniques for closing an opening in a tissue and more particularly, to occlusion devices for closing anatomical defects in tissue such as defects consisting of an opening connecting a front side and a back side of a tissue. More particularly the present invention relates to occlusion devices for closing septal abnormalities such as atrial septal defects and patent foramen ovale, delivering systems for such occlusion devices, kits comprising the occlusion devices and the delivering systems and to methods of closing an anatomical defect in a tissue consisting of an opening connecting a front side and a back side of a tissue.Figure 2",UNIV NANYANG TECH,VENKATRAMAN SUBRAMANIAN;;BOEY YIN CHIANG FREDDY;;WU WEI;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,,https://lens.org/099-450-033-019-745,Patent Application,no,0,0,8,8,0,A61B17/0057;;A61B17/0057;;A61B2017/00243;;A61B2017/00243;;A61B2017/00592;;A61B2017/00592;;A61B2017/00597;;A61B2017/00597;;A61B2017/00606;;A61B2017/00606;;A61B2017/00619;;A61B2017/00619;;A61B2017/00623;;A61B2017/00623;;A61B2090/3966;;A61B2090/3966,,,0,0,,,,PENDING
50,SG,A,SG 10201610494V A,007-856-098-417-237,2017-02-27,2017,SG 10201610494V A,2010-12-17,US 28754409 P,2009-12-17,Occlusion Device for Closing Anatomical Defects,,UNIV NANYANG TECH,VENKATRAMAN SUBRAMANIAN;;BOEY YIN CHIANG FREDDY;;WU WEI;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,,https://lens.org/007-856-098-417-237,Unknown,no,0,0,8,8,0,A61B17/0057;;A61B17/0057;;A61B2017/00243;;A61B2017/00243;;A61B2017/00592;;A61B2017/00592;;A61B2017/00597;;A61B2017/00597;;A61B2017/00606;;A61B2017/00606;;A61B2017/00619;;A61B2017/00619;;A61B2017/00623;;A61B2017/00623;;A61B2090/3966;;A61B2090/3966,,,0,0,,,,PENDING
51,US,A1,US 2013/0046254 A1,116-357-768-523-211,2013-02-21,2013,US 201013516065 A,2010-12-17,US 201013516065 A;;US 28754409 P;;SG 2010000476 W,2009-12-17,OCCLUSION DEVICE FOR CLOSING ANATOMICAL DEFECTS,"The present invention generally relates to the field of transcatheter device closure techniques for closing an opening in a tissue and more particularly, to occlusion devices for closing anatomical defects in tissue such as defects consisting of an opening connecting a front side and a back side of a tissue. More particularly the present invention relates to occlusion devices for closing septal abnormalities such as atrial septal defects and patent foramen ovale, delivering systems for such occlusion devices, kits comprising the occlusion devices and the delivering systems and to methods of closing an anatomical defect in a tissue consisting of an opening connecting a front side and a back side of a tissue.",UNIV NANYANG TECH;;VENKATRAMAN SUBRAMANIAN;;BOEY YIN CHIANG FREDDY;;WU WEI;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,VENKATRAMAN SUBRAMANIAN;;BOEY YIN CHIANG FREDDY;;WU WEI;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,NANYANG TECHNOLOGICAL UNIVERSITY (2012-07-19),https://lens.org/116-357-768-523-211,Patent Application,yes,25,6,8,8,0,A61B17/0057;;A61B17/0057;;A61B2017/00243;;A61B2017/00243;;A61B2017/00592;;A61B2017/00592;;A61B2017/00597;;A61B2017/00597;;A61B2017/00606;;A61B2017/00606;;A61B2017/00619;;A61B2017/00619;;A61B2017/00623;;A61B2017/00623;;A61B2090/3966;;A61B2090/3966,A61B17/03;;A61M25/00,604/264;;606/213,1,0,,,synonym: fold; http://www.thesaurus.com/browse/fold; 03/10/16.,ACTIVE
52,WO,A8,WO 2011/075088 A8,043-796-783-104-750,2011-09-15,2011,SG 2010000476 W,2010-12-17,US 28754409 P,2009-12-17,OCCLUSION DEVICE FOR CLOSING ANATOMICAL DEFECTS,"The present invention generally relates to the field of transcatheter device closure techniques for closing an opening in a tissue and more particularly, to occlusion devices for closing anatomical defects in tissue such as defects consisting of an opening connecting a front side and a back side of a tissue. More particularly the present invention relates to occlusion devices for closing septal abnormalities such as atrial septal defects and patent foramen ovale, delivering systems for such occlusion devices, kits comprising the occlusion devices and the delivering systems and to methods of closing an anatomical defect in a tissue consisting of an opening connecting a front side and a back side of a tissue.",UNIV NANYANG TECH;;VENKATRAMAN SUBRAMANIAN;;BOEY YIN CHIANG FREDDY;;WU WEI;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,VENKATRAMAN SUBRAMANIAN;;BOEY YIN CHIANG FREDDY;;WU WEI;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,,https://lens.org/043-796-783-104-750,Amended Application,yes,0,1,8,8,0,A61B17/0057;;A61B17/0057;;A61B2017/00243;;A61B2017/00243;;A61B2017/00592;;A61B2017/00592;;A61B2017/00597;;A61B2017/00597;;A61B2017/00606;;A61B2017/00606;;A61B2017/00619;;A61B2017/00619;;A61B2017/00623;;A61B2017/00623;;A61B2090/3966;;A61B2090/3966,A61B17/03,,0,0,,,,PENDING
53,EP,A1,EP 4204933 A1,067-482-133-030-859,2023-07-05,2023,EP 21787090 A,2021-08-25,US 202063071096 P;;US 202063117537 P;;US 2021/0047628 W,2020-08-27,MECHANICALLY SENSITIVE POWER EFFICIENT STYLUS FOR AN ELECTRONIC DEVICE,,SHAPIRTEN LABORATORIES LLC,BECHSTEIN DANIEL J;;DUONG DUC T;;SMITH JOHN S;;VOSGUERITCHIAN MICHAEL;;FILIZ SINAN;;AYANOOR-VITIKKATE VIPIN;;SHARMA VYOM,,https://lens.org/067-482-133-030-859,Patent Application,yes,0,0,4,4,0,G06F3/03545;;G06F3/0383;;G06F2203/0384;;G06F2203/0382;;G06F3/04166;;G06F2203/04101;;G06F3/03545;;G06F3/0383,G06F3/0354;;G06F3/044,,0,0,,,,PENDING
54,WO,A1,WO 2011/075088 A1,053-617-425-039-73X,2011-06-23,2011,SG 2010000476 W,2010-12-17,US 28754409 P,2009-12-17,OCCLUSION DEVICE FOR CLOSING ANATOMICAL DEFECTS,"The present invention generally relates to the field of transcatheter device closure techniques for closing an opening in a tissue and more particularly, to occlusion devices for closing anatomical defects in tissue such as defects consisting of an opening connecting a front side and a back side of a tissue. More particularly the present invention relates to occlusion devices for closing septal abnormalities such as atrial septal defects and patent foramen ovale, delivering systems for such occlusion devices, kits comprising the occlusion devices and the delivering systems and to methods of closing an anatomical defect in a tissue consisting of an opening connecting a front side and a back side of a tissue.",UNIV NANYANG TECH;;VENKATRAMAN SUBRAMANIAN;;BOEY YIN CHIANG FREDDY;;WU WEI;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,VENKATRAMAN SUBRAMANIAN;;BOEY YIN CHIANG FREDDY;;WU WEI;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,,https://lens.org/053-617-425-039-73X,Patent Application,yes,4,4,8,8,0,A61B17/0057;;A61B17/0057;;A61B2017/00243;;A61B2017/00243;;A61B2017/00592;;A61B2017/00592;;A61B2017/00597;;A61B2017/00597;;A61B2017/00606;;A61B2017/00606;;A61B2017/00619;;A61B2017/00619;;A61B2017/00623;;A61B2017/00623;;A61B2090/3966;;A61B2090/3966,A61B17/03,,0,0,,,,PENDING
55,SG,A,SG 10201913438W A,198-548-227-340-160,2020-03-30,2020,SG 10201913438W A,2010-12-17,US 28754409 P,2009-12-17,Occlusion Device for Closing Anatomical Defects,,UNIV NANYANG TECH,VENKATRAMAN SUBRAMANIAN;;BOEY YIN CHIANG FREDDY;;WU WEI;;TANG YONG-DAN;;YIP WEI LUEN JAMES;;DUONG HONG DUC,,https://lens.org/198-548-227-340-160,Unknown,no,0,0,8,8,0,A61B17/0057;;A61B17/0057;;A61B2017/00243;;A61B2017/00243;;A61B2017/00592;;A61B2017/00592;;A61B2017/00597;;A61B2017/00597;;A61B2017/00606;;A61B2017/00606;;A61B2017/00619;;A61B2017/00619;;A61B2017/00623;;A61B2017/00623;;A61B2090/3966;;A61B2090/3966,,,0,0,,,,PENDING
56,US,A1,US 2023/0273687 A1,166-948-948-589-507,2023-08-31,2023,US 202118043312 A,2021-08-25,US 202118043312 A;;US 202063117537 P;;US 202063071096 P;;US 2021/0047628 W,2020-08-27,MECHANICALLY SENSITIVE POWER EFFICIENT STYLUS FOR AN ELECTRONIC DEVICE,"An input device comprising: a printed circuit board (PCB) comprising non-linear circuitry; resistive circuitry including a force-sensitive resistor (FSR) coupled to the PCB in parallel with the non-linear circuitry; and a hinge coupled to the PCB and the FSR configured to strain the FSR in response to a force applied to a tip of the input device. A stylus comprising: a housing; and stylus circuitry at least partially positioned within the housing, wherein the stylus circuitry comprises: body circuitry; a front tip interface; and front tip stylus circuitry positioned between and electrically coupled to the body circuitry and the front tip interface, wherein the front tip stylus circuitry comprises non-linear circuitry in parallel with physical interaction characteristic (PIC) circuitry; wherein the front tip stylus circuitry is operative to provide a non-linear load between the body circuitry and the front tip interface when the stylus is stimulated by an external stimulation; wherein the non-linear load is operative to provide a stylus electric field that is detectable by an electronic device when the front tip interface of the stylus is positioned adjacent an input surface of the electronic device; and wherein a resistance of the PIC circuitry is adjustable based on a force applied to the tip interface or based on a tilt angle of the stylus. An electronic device comprising: a plurality of first electrodes; a plurality of second electrodes; stimulation and sensing circuitry configured to transmit signals on the plurality of first electrodes and sense receive signals on the plurality of second electrodes; and processing circuitry configured to: extract, from the sensed receive signals, data indicative of a non-linear response to the transmit signals; estimate a position of an accessory on a surface of the electronic device based on the extracted data; and estimate a force applied to the accessory in contact with the surface of the electronic device or a tilt angle of the accessory relative to the surface of the electronic device based on the extracted data.",SHAPIRTEN LABORATORIES LLC,BECHSTEIN DANIEL J;;DUONG DUC T;;SMITH JOHN S;;VOSGUERITCHIAN MICHAEL;;FILIZ SINAN;;AYANOOR-VITIKKATE VIPIN;;SHARMA VYOM,,https://lens.org/166-948-948-589-507,Patent Application,yes,4,1,4,4,0,G06F3/03545;;G06F3/0383;;G06F2203/0384;;G06F2203/0382;;G06F3/04166;;G06F2203/04101;;G06F3/03545;;G06F3/0383,G06F3/0354;;G06F3/038,,0,0,,,,PENDING
57,US,A1,US 2023/0328054 A1,062-261-095-652-065,2023-10-12,2023,US 202117346299 A,2021-06-14,US 202117346299 A,2021-06-14,AUTONOMOUS CONTROL AND SECURE COMMUNICATIONS SYSTEM AND METHODS FOR SENSORS,"A networked computer system providing an automated control system that enables a sensor client to securely communicate with a heterogeneous set of unique sensors. The system enables autonomous secure identification of specific sensors capable of system inter-operation. Recognized sensors are autonomously paired and the connection secured using a password unique to the sensor and autonomously managed by the system. Measurement data is source encrypted using a well-defined public key, thereby providing data security that extends uninterrupted from the sensor itself to an appropriately authorized subsystem of the control system.",NGUYEN KELLY DAO XUAN;;PHAM DUC NGOC;;TRUONG TRI NGOC;;PHAN VU TUAN;;BUI HA THI THU;;RANE ANVAY ARVIND;;DUONG BAO HUYNH,NGUYEN KELLY DAO XUAN;;PHAM DUC NGOC;;TRUONG TRI NGOC;;PHAN VU TUAN;;BUI HA THI THU;;RANE ANVAY ARVIND;;DUONG BAO HUYNH,,https://lens.org/062-261-095-652-065,Patent Application,yes,10,0,1,1,0,H04L63/083;;H04L63/0876;;H04L63/0435;;H04L63/083;;H04L63/0435;;H04L63/0876,H04L9/40,,1,0,,,NPL Search History (Year: 2023),PENDING
58,US,A1,US 2024/0048539 A1,009-155-914-457-108,2024-02-08,2024,US 202117346836 A,2021-06-14,US 202117346836 A,2021-06-14,NETWORK TRANSPORT INDEPENDENT ENCRYPTED SENSOR DATA TRANSPORT SYSTEM AND METHODS,"A sensor communications system provides for the secure transfer of sensor measurement data from sensor devices to a remote, network connected server system. The sensor devices include processor to encrypt a sensor measurement data stream using the public key of an asymmetric key pair and to transmit the encrypted sensor measurement data stream through the local network interface. The remote server system includes a network gateway and a compute server with the compute server being couplable to the network gateway and an authorization server storing the private key of the asymmetric key pair. The compute server operates to decrypt the encrypted sensor measurement data stream using the private key and to process the decrypted sensor measurement data stream for presentation a user of the remote server system.",NGUYEN KELLY DAO XUAN;;PHAM DUC NGOC;;TRUONG TRI NGOC;;PHAN VU TUAN;;BUI HA THI THU;;RANE ANVAY ARVID;;DUONG BAO HUYNH,NGUYEN KELLY DAO XUAN;;PHAM DUC NGOC;;TRUONG TRI NGOC;;PHAN VU TUAN;;BUI HA THI THU;;RANE ANVAY ARVID;;DUONG BAO HUYNH,,https://lens.org/009-155-914-457-108,Patent Application,yes,5,0,1,1,0,H04L63/0442;;H04L9/14;;H04L63/0442,H04L9/40;;H04L9/14,,0,0,,,,PENDING
59,EP,A1,EP 2710019 A1,179-774-843-723-137,2014-03-26,2014,EP 12725570 A,2012-05-18,US 201161488133 P;;US 2012/0038615 W,2011-05-19,PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS,,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/179-774-843-723-137,Patent Application,yes,0,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,1,0,,,See references of WO 2012159047A1,ACTIVE
60,AU,A1,AU 2019/226278 A1,067-987-072-085-605,2019-09-26,2019,AU 2019/226278 A,2019-09-09,AU 2019/226278 A;;AU 2018/200776 A;;AU 2016/208292 A;;AU 2012/255029 A;;US 201161488133 P;;US 2012/0038615 W,2011-05-19,PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS,I:\sxd\Interwovn\NRPortbl\DCC\SXD\6383981 L.docx-l/02/2018 The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/067-987-072-085-605,Patent Application,no,0,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,0,0,,,,DISCONTINUED
61,CA,A1,CA 2835932 A1,057-069-609-218-258,2012-11-22,2012,CA 2835932 A,2012-05-18,US 201161488133 P;;US 2012/0038615 W,2011-05-19,PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS,The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/057-069-609-218-258,Patent Application,no,0,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,0,0,,,,ACTIVE
62,ES,T3,ES 2700470 T3,051-230-878-284-130,2019-02-15,2019,ES 16204289 T,2012-05-18,US 201161488133 P,2011-05-19,Procesos e intermediarios para la preparación de agentes anti-VIH,"Un compuesto seleccionado de:**Fórmula** en donde; Bn está opcionalmente sustituido con uno o más grupos seleccionados de (C1-C6)alquilo y -O(C1-C6)alquilo; cada R1 es independientemente -C(=O)arilo, en donde el -C(=O)arilo está opcionalmente sustituido con uno o más grupos (C1-C6)alquilo; cada R2 es independientemente alquilo(C1-C6); R3 es I, R5Se o R5S; cada R4 es independientemente arilo, en donde el arilo está opcionalmente sustituido con uno o más grupos (C1-C6)alquilo; y cada R5 es independientemente (C1-C6)alquilo, (C3-C7)cicloalquilo o arilo, en donde el arilo o(C3- C7)cicloalquilo está opcionalmente sustituido con uno o más grupos (C1-C6)alquilo; y sus sales de los mismos.",GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/051-230-878-284-130,Granted Patent,no,0,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,0,0,,,,ACTIVE
63,JP,A,JP 2019089808 A,061-027-344-765-625,2019-06-13,2019,JP 2019017324 A,2019-02-01,US 201161488133 P,2011-05-19,PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS,"To provide synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.SOLUTION: The present invention provides processes for preparing the compound of formula 13 or salts or stereoisomers thereof, wherein, the present invention can be achieved by the bonding of an amide derivative of phosphate and a tetrahydrofuran derivative with an adenylate group bonded thereto.SELECTED DRAWING: None",GILEAD SCIENCES INC,RICHARD HUNG CHIU YU;;BRANDON HEATH BROWN;;RICHARD P POLNIASZEK;;BENJAMIN R GRAETZ;;SUJINO KEIKO;;DUONG DUC-PHI TRAN;;ALAN SCOTT TRIMAN;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/061-027-344-765-625,Patent Application,no,0,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/6558;;C07H19/16;;C07H19/20,,0,0,,,,PENDING
64,AU,A1,AU 2018/200776 A1,086-893-295-816-139,2018-02-22,2018,AU 2018/200776 A,2018-02-01,AU 2018/200776 A;;AU 2016/208292 A;;AU 2012/255029 A;;US 201161488133 P;;US 2012/0038615 W,2011-05-19,Processes and intermediates for preparing anti-HIV agents,I: \sxd\Interwoven\NRPortbl\DCC\SXD\ 638398 1 Idocx- 102 2018 The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/086-893-295-816-139,Patent Application,no,0,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,0,0,,,,ACTIVE
65,WO,A1,WO 2012/159047 A1,100-814-498-507-659,2012-11-22,2012,US 2012/0038615 W,2012-05-18,US 201161488133 P,2011-05-19,PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS,The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,GILEAD SCIENCES INC;;YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/100-814-498-507-659,Patent Application,no,7,6,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,4,4,009-712-645-664-860;;030-286-349-224-117;;044-156-633-677-511;;028-107-122-272-132,20391198;;10.1080/15257771003597758;;18164198;;10.1016/j.bmcl.2007.11.125;;11563079;;10.1081/ncn-100002338;;10.1016/s0960-894x(01)00128-7;;11327587,"YANA CEN ET AL: ""Efficient Syntheses of Clofarabine and Gemcitabine From 2-Deoxyribonolactone"", NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS, vol. 29, no. 2, 26 February 2010 (2010-02-26), pages 113 - 122, XP055030987, ISSN: 1525-7770, DOI: 10.1080/15257771003597758;;BOOJAMRA ET AL: ""Synthesis and anti-HIV activity of GS-9148 (2'-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitor"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 18, no. 3, 5 December 2007 (2007-12-05), pages 1120 - 1123, XP022475698, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2007.11.125;;CHAPMAN H ET AL: ""Practical synthesis, separation, and stereochemical assignment of the PMPA pro-drug GS-7340"", NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS, TAYLOR & FRANCIS, PHILADELPHIA, PA, vol. 20, no. 4-7, 1 January 2001 (2001-01-01), pages 621 - 628, XP002202043, ISSN: 1525-7770, DOI: 10.1081/NCN-100002338;;BALLATORE C ET AL: ""SYNTHESIS AND EVALUATION OF NOVEL AMIDATE PRODRUGS OF PMEA AND PMPA"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 11, 1 January 2001 (2001-01-01), pages 1053 - 1056, XP001180825, ISSN: 0960-894X, DOI: 10.1016/S0960-894X(01)00128-7",PENDING
66,US,A1,US 2012/0296076 A1,093-515-882-076-783,2012-11-22,2012,US 201213475569 A,2012-05-18,US 201213475569 A;;US 201161488133 P,2011-05-19,PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS,The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,GILEAD SCIENCES INC (2012-06-15),https://lens.org/093-515-882-076-783,Patent Application,yes,0,3,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07H19/16;;C07F1/00;;C07F9/28;;C07F9/40;;C07F9/6561;;C07H23/00,536/26.2;;544/244;;558/187;;558/179;;536/27.22;;536/27.62;;558/215;;536/26.7,1,1,065-794-795-000-894,10.1128/aac.01209-07;;pmc2224749;;18056281,"Ray et al. Antimicrobial Agents and Chemotherapy (2008), Vol. 52, pages 648-654.",ACTIVE
67,PT,T,PT 3199537 T,033-533-526-949-309,2019-01-17,2019,PT 16204289 T,2012-05-18,US 201161488133 P,2011-05-19,PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS,,GILEAD SCIENCES INC,BENJAMIN R GRAETZ;;RICHARD HUNG CHIU YU;;RICHARD P POLNIASZEK;;BRANDON HEATH BROWN;;KEIKO SUJINO;;DUONG DUC-PHI TRAN;;ALAN SCOTT TRIMAN;;KENNETH M KENT;;STEVEN PFEIFFER,,https://lens.org/033-533-526-949-309,Patent Application,no,0,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,0,0,,,,PENDING
68,TW,A,TW 201309715 A,056-294-943-862-983,2013-03-01,2013,TW 101117811 A,2012-05-18,US 201161488133 P,2011-05-19,Processes and intermediates for preparing anti-HIV agents,The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/056-294-943-862-983,Patent of Addition,no,0,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/40;;C07F9/44;;C07F9/6561;;C07H19/16,,0,0,,,,ACTIVE
69,TW,B,TW I635093 B,022-943-360-882-88X,2018-09-11,2018,TW 101117811 A,2012-05-18,US 201161488133 P,2011-05-19,Processes and intermediates for preparing anti-hiv agents,,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/022-943-360-882-88X,Granted Patent,no,4,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,,,0,0,,,,ACTIVE
70,JP,A,JP 2016128459 A,046-550-206-631-613,2016-07-14,2016,JP 2016005955 A,2016-01-15,US 201161488133 P,2011-05-19,PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS,"PROBLEM TO BE SOLVED: To provide synthetic processes and synthetic intermediates that can be used to prepare compounds having anti-HIV properties.SOLUTION: The present invention provides compounds being phosphonamidate derivatives of (2R',5R')-9-(3-fluoro-2,5-dihydro-5-phosphonomethoxy-2-furanyl)adenine represented by formula 13 having anti-HIV properties, or salts or stereoisomers thereof. Also provided are novel synthetic processes and synthetic intermediates useful for preparing the compounds.SELECTED DRAWING: None",GILEAD SCIENCES INC,RICHARD HUNG CHIU YU;;BRANDON HEATH BROWN;;RICHARD P POLNIASZEK;;BENJAMIN R GRAETZ;;SUJINO KEIKO;;DUONG DUC-PHI TRAN;;ALAN SCOTT TRIMAN;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/046-550-206-631-613,Patent Application,no,3,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/6561;;C07F9/44,,1,1,022-735-493-809-911,10.1002/chin.198449253,"LUDEWIG, DOERTE; EISERBECK, WOLFGANG; FEIKE, EGBERT: ""Preparation of diester and monoester salts of phosphorous acid from phosphorus(III) oxide and second"", ZEITSCHRIFT FUER CHEMIE, vol. 24(8), JPN6016044380, 1984, pages 290-1",ACTIVE
71,CA,C,CA 2835932 C,088-513-747-832-718,2020-03-24,2020,CA 2835932 A,2012-05-18,US 201161488133 P;;US 2012/0038615 W,2011-05-19,PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS,The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/088-513-747-832-718,Granted Patent,no,0,0,39,39,0,C07D473/34;;C07F9/4075;;C07F9/4449;;C07H19/16;;C07H19/02;;C07H19/04;;C07H19/173;;A61K31/66;;C07F9/65616;;C07H19/20;;C07H23/00;;C07H19/02;;C07H19/04;;C07H19/173;;A61K31/66;;C07D473/34;;C07F9/4075;;C07F9/4449;;C07H19/16;;C07F9/65616;;C07H19/20;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,0,0,,,,ACTIVE
72,US,A1,US 2015/0203525 A1,115-947-993-081-740,2015-07-23,2015,US 201514615357 A,2015-02-05,US 201514615357 A;;US 201213475569 A;;US 201161488133 P,2011-05-19,PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS,The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,GILEAD SCIENCES INC (2012-06-15),https://lens.org/115-947-993-081-740,Patent Application,yes,0,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07H23/00;;C07F9/6561;;C07H19/16,,0,0,,,,ACTIVE
73,NZ,A,NZ 618939 A,050-250-615-689-744,2015-11-27,2015,NZ 61893912 A,2012-05-18,US 2012/0038615 W;;US 201161488133 P,2011-05-19,Processes and intermediates for preparing anti-hiv agents,Disclosed are processes for the preparation of compounds having useful anti-HIV properties. Also disclosed are intermediates used in these processes.,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/050-250-615-689-744,Patent Application,no,0,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,0,0,,,,DISCONTINUED
74,EP,B1,EP 3199537 B1,116-869-881-036-940,2018-10-17,2018,EP 16204289 A,2012-05-18,US 201161488133 P;;EP 12725570 A;;US 2012/0038615 W,2011-05-19,PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS,,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/116-869-881-036-940,Granted Patent,yes,3,0,39,39,0,C07D473/34;;C07F9/4075;;C07F9/4449;;C07H19/16;;C07H19/02;;C07H19/04;;C07H19/173;;A61K31/66;;C07F9/65616;;C07H19/20;;C07H23/00;;C07H19/02;;C07H19/04;;C07H19/173;;A61K31/66;;C07D473/34;;C07F9/4075;;C07F9/4449;;C07H19/16;;C07F9/65616;;C07H19/20;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,2,0,,,"YANA CEN ET AL: ""Efficient Syntheses of Clofarabine and Gemcitabine From 2-Deoxyribonolactone"", NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS, vol. 29, no. 2, 26 February 2010 (2010-02-26), pages 113-122, XP055030987, ISSN: 1525-7770, DOI: 10.1080/15257771003597758;;BOOJAMRA ET AL: ""Synthesis and anti-HIV activity of GS-9148 (2'-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitor"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 18, no. 3, 5 December 2007 (2007-12-05), pages 1120-1123, XP022475698, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2007.11.125",ACTIVE
75,PT,T,PT 2710019 T,006-511-481-014-852,2017-07-21,2017,PT 12725570 T,2012-05-18,US 201161488133 P,2011-05-19,PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS,,GILEAD SCIENCES INC,RICHARD HUNG CHIU YU;;BRANDON HEATH BROWN;;RICHARD P POLNIASZEK;;BENJAMIN R GRAETZ;;KEIKO SUJINO;;DUONG DUC-PHI TRAN;;ALAN SCOTT TRIMAN;;KENNETH M KENT;;STEVEN PFEIFFER,,https://lens.org/006-511-481-014-852,Patent Application,no,0,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,0,0,,,,PENDING
76,AU,A1,AU 2016/208292 A1,143-926-230-830-339,2016-08-11,2016,AU 2016/208292 A,2016-07-26,AU 2016/208292 A;;AU 2012/255029 A;;US 201161488133 P;;US 2012/0038615 W,2011-05-19,Processes and intermediates for preparing anti-HIV agents,H:\rec\Interwoven\NRPortbl\DCC\REC\05017491 .docx-15/07/2016 The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/143-926-230-830-339,Patent Application,no,0,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,0,0,,,,ACTIVE
77,EP,B1,EP 2710019 B1,059-706-255-996-432,2017-05-03,2017,EP 12725570 A,2012-05-18,US 201161488133 P;;US 2012/0038615 W,2011-05-19,PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS,,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/059-706-255-996-432,Granted Patent,yes,7,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,4,0,,,"YANA CEN ET AL: ""Efficient Syntheses of Clofarabine and Gemcitabine From 2-Deoxyribonolactone"", NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS, vol. 29, no. 2, 26 February 2010 (2010-02-26), pages 113-122, XP55030987, ISSN: 1525-7770, DOI: 10.1080/15257771003597758;;BOOJAMRA ET AL: ""Synthesis and anti-HIV activity of GS-9148 (2'-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitor"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 18, no. 3, 5 December 2007 (2007-12-05), pages 1120-1123, XP022475698, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2007.11.125;;CHAPMAN H ET AL: ""Practical synthesis, separation, and stereochemical assignment of the PMPA pro-drug GS-7340"", NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS, TAYLOR & FRANCIS, PHILADELPHIA, PA, vol. 20, no. 4-7, 1 January 2001 (2001-01-01), pages 621-628, XP002202043, ISSN: 1525-7770, DOI: 10.1081/NCN-100002338;;BALLATORE C ET AL: ""SYNTHESIS AND EVALUATION OF NOVEL AMIDATE PRODRUGS OF PMEA AND PMPA"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 11, 1 January 2001 (2001-01-01), pages 1053-1056, XP001180825, ISSN: 0960-894X, DOI: 10.1016/S0960-894X(01)00128-7",ACTIVE
78,JP,A,JP 2017110025 A,136-219-963-701-917,2017-06-22,2017,JP 2017019959 A,2017-02-06,US 201161488133 P,2011-05-19,PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS,"PROBLEM TO BE SOLVED: To provide synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.SOLUTION: The present invention provides novel synthetic processes and synthetic intermediates useful to prepare compounds that are phosphonamidate derivatives of (2R',5R')-9-(3-fluoro-2,5-dihydro-5-phosphonomethoxy-2-furanyl)adenine, represented by formula 13, or its salt or stereoisomer.SELECTED DRAWING: None",GILEAD SCIENCES INC,RICHARD HUNG CHIU YU;;BRANDON HEATH BROWN;;RICHARD P POLNIASZEK;;BENJAMIN R GRAETZ;;SUJINO KEIKO;;DUONG DUC-PHI TRAN;;ALAN SCOTT TRIMAN;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/136-219-963-701-917,Patent Application,no,5,0,39,39,0,C07D473/34;;C07F9/4075;;C07F9/4449;;C07H19/16;;C07H19/02;;C07H19/04;;C07H19/173;;A61K31/66;;C07F9/65616;;C07H19/20;;C07H23/00;;C07H19/02;;C07H19/04;;C07H19/173;;A61K31/66;;C07D473/34;;C07F9/4075;;C07F9/4449;;C07H19/16;;C07F9/65616;;C07H19/20;;C07H23/00,C07F9/655;;C07F9/09;;C07F9/24;;C07H19/16,,1,1,030-286-349-224-117,18164198;;10.1016/j.bmcl.2007.11.125,"BOOJAMRA C. G. ET AL, BIOORG. MED. CHEM. LETT., vol. vol.18, JPN6015041508, 2008, pages 1120 - 1123",ACTIVE
79,US,B2,US 9296779 B2,198-967-674-431-271,2016-03-29,2016,US 201514615357 A,2015-02-05,US 201514615357 A;;US 201213475569 A;;US 201161488133 P,2011-05-19,Processes and intermediates for preparing anti-HIV agents,The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,GILEAD SCIENCES INC (2012-06-15),https://lens.org/198-967-674-431-271,Granted Patent,yes,14,3,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07H19/00;;C07D473/34;;C07F9/40;;C07F9/44;;C07F9/6561;;C07H19/02;;C07H19/04;;C07H19/16;;C07H19/173;;C07H19/20;;C07H19/22;;C07H23/00,,16,9,003-944-913-687-458;;028-107-122-272-132;;030-286-349-224-117;;009-712-645-664-860;;044-156-633-677-511;;051-227-489-933-144;;015-518-911-586-809;;137-274-061-088-365;;065-794-795-000-894,10.1021/ja00206a058;;10.1016/s0960-894x(01)00128-7;;11327587;;18164198;;10.1016/j.bmcl.2007.11.125;;20391198;;10.1080/15257771003597758;;11563079;;10.1081/ncn-100002338;;10.1021/jo00199a026;;15058965;;10.1021/jo035508+;;10.1016/s0957-4166(98)00331-0;;10.1128/aac.01209-07;;pmc2224749;;18056281,"Australian Office Action dated Jan. 27, 2015 for Australian Patent Application No. 2012255029.;;Avila et al. (1989). ""Phosphonium Ion Fragmentations Relevant to Organophosphonate Biodegradation,"" J. Am. Chem. Soc. 111:8969-8970.;;Ballatore, C. et al. (Apr. 23, 2001). ""Synthesis and Evaluation of Novel Amidate Prodrugs of PMEA and PMPA,"" Bioorganic & Medicinal Chem. Letters 11(8):1053-1056.;;Boojamra, C.G. et al. (Feb. 1, 2008, e-pub. Dec. 5, 2007). ""Synthesis and Anti-HIV Activity of GS-9148 (2' -Fd4AP), a Novel Nucleoside Phosphonate HIV Reverse Transcriptase Inhibitor,"" Bioorganic & Medicinal Chem. Letters 18(3):1120-1123.;;Cen, Y. et al. (Feb. 2010). ""Efficient Syntheses of Clofarabine and Gemcitabine from 2-Deoxyribonolactone,"" Nucleosides, Nucleotides and Nucleic Acids 29(2):113-122.;;Chapman, H. et al. (Apr.-Jul. 2001). ""Practical Synthesis, Separation, and Stereochemical Assignment of the PMPA Pro-Drug GS-7340,"" Nucleosides, Nucleotides & Nucleic Acids 20(4-7):621-628.;;Fry et al. (1984). ""Alkylations Using Methyltrialkoxyphosphonium Tetrafluoborate Salts. Synthetic and Mechanistic Aspects of Methyl, Ethyl, 2-Propyl, and 2-Octyl Group Transfers,"" J. Org. Chem. 49:4877-4880.;;Hersh et al. (Mar. 19, 2004). ""Synthesis and Structural Characterization of Trivalent Amino Acid Derived Chiral Phosphorus Compounds,"" J. Org. Chem. 69(6):2153-2163.;;Kielbasinski et al. (1998). ""Lipase-Promoted Kinetic Resolution of Racemic, P-Chiral Hydroxymethylphosphonates and Phosphinates,"" Tetrahedron: Asymmetry 9:3283-3287.;;Ray, A.S. et al. (Feb. 2008; e-pub. Dec. 3, 2007). ""Intracellular Metabolism of the Nucleotide Prodrug GS-9131, a Potent Anti-Human Immunodeficiency Virus Agent,"" Antimicrob. Agents Chemother. 52(2):648-654.;;Notice of Allowance mailed on Aug. 29, 2014, for U.S. Appl. No. 13/475,569, filed May 18, 2012, 8 pages.;;Notice of Allowance mailed on Nov. 7, 2014, for U.S. Appl. No. 13/475,569, filed May 18, 2012, 5 pages.;;International Search Report mailed on Jul. 20, 2012 for PCT Patent Application No. PCT/US2012/038615 filed on May 18, 2012, 6 pages.;;New Zealand Office Action mailed on Aug. 20, 2014, for New Zealand Patent Application No. 618939, filed on May 18, 2012, 2 pages.;;Written Opinion of the International Searching Authority mailed on Jul. 20, 2012 for PCT Patent Application No. PCT/US2012/038615 filed on May 18, 2012, 8 pages.;;Office Acton issued Oct. 16, 2015 for Japanese Appl. No. 2014-511589.",ACTIVE
80,EP,A1,EP 3450438 A1,160-748-930-852-501,2019-03-06,2019,EP 18200819 A,2012-05-18,US 201161488133 P;;EP 16204289 A;;EP 12725570 A;;US 2012/0038615 W,2011-05-19,PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS,The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/160-748-930-852-501,Patent Application,yes,9,0,39,39,0,C07D473/34;;C07F9/4075;;C07F9/4449;;C07H19/16;;C07H19/02;;C07H19/04;;C07H19/173;;A61K31/66;;C07F9/65616;;C07H19/20;;C07H23/00;;C07H19/02;;C07H19/04;;C07H19/173;;A61K31/66;;C07D473/34;;C07F9/4075;;C07F9/4449;;C07H19/16;;C07F9/65616;;C07H19/20;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,3,2,025-533-852-354-159;;135-304-912-500-023,10.1016/b978-0-12-040811-5.50011-1;;10.1021/jo00219a048,"T. W. GREENE: ""Protecting Groups In Organic Synthesis"", 1981, WILEY;;TANN, C.H., J. ORG. CHEM., vol. 50, 1985, pages 3644 - 3647;;REC. TRAC. CHIM PAYS-BAS, vol. 105, 1986, pages 528 - 537",DISCONTINUED
81,AU,A1,AU 2012/255029 A1,072-085-059-160-496,2013-05-02,2013,AU 2012/255029 A,2012-05-18,US 201161488133 P;;US 2012/0038615 W,2011-05-19,Processes and intermediates for preparing anti-HIV agents,The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,KENT KENNETH;;TRIMAN ALAN;;TRAN DUONG;;GRAETZ BENJAMIN;;PFEIFFER STEVEN;;BROWN BRANDON;;POLNIASZEK RICHARD;;YU RICHARD;;GILEAD SCIENCES INC;;SUJINO KEIKO,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/072-085-059-160-496,Patent Application,no,0,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,0,0,,,,ACTIVE
82,AU,B2,AU 2016/208292 B2,119-986-829-216-807,2018-02-22,2018,AU 2016/208292 A,2016-07-26,AU 2016/208292 A;;AU 2012/255029 A;;US 201161488133 P;;US 2012/0038615 W,2011-05-19,Processes and intermediates for preparing anti-HIV agents,H:\rec\Interwoven\NRPortbl\DCC\REC\05017491 .docx-15/07/2016 The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/119-986-829-216-807,Granted Patent,no,3,0,39,39,0,C07D473/34;;C07F9/4075;;C07F9/4449;;C07H19/16;;C07H19/02;;C07H19/04;;C07H19/173;;A61K31/66;;C07F9/65616;;C07H19/20;;C07H23/00;;C07H19/02;;C07H19/04;;C07H19/173;;A61K31/66;;C07D473/34;;C07F9/4075;;C07F9/4449;;C07H19/16;;C07F9/65616;;C07H19/20;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,0,0,,,,ACTIVE
83,AU,B2,AU 2018/200776 B2,071-039-260-271-901,2019-10-03,2019,AU 2018/200776 A,2018-02-01,AU 2018/200776 A;;AU 2016/208292 A;;AU 2012/255029 A;;US 201161488133 P;;US 2012/0038615 W,2011-05-19,Processes and intermediates for preparing anti-HIV agents,I:\sxd\Interwovn\NRPortbl\DCC\SXD\638398 1 Idocx-l/02/2018 The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/071-039-260-271-901,Granted Patent,no,2,0,39,39,0,C07D473/34;;C07F9/4075;;C07F9/4449;;C07H19/16;;C07H19/02;;C07H19/04;;C07H19/173;;A61K31/66;;C07F9/65616;;C07H19/20;;C07H23/00;;C07H19/02;;C07H19/04;;C07H19/173;;A61K31/66;;C07D473/34;;C07F9/4075;;C07F9/4449;;C07H19/16;;C07F9/65616;;C07H19/20;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,0,0,,,,ACTIVE
84,ES,T3,ES 2629913 T3,095-924-814-084-802,2017-08-16,2017,ES 12725570 T,2012-05-18,US 201161488133 P;;US 2012/0038615 W,2011-05-19,Procesos e intermediarios para la preparación de agentes anti-VIH,"Un compuesto que es:**Fórmula** en la que W es halógeno o -OS(O)2RL, RL es (C1-C6)alquilo o arilo, en el que (C1-C6)alquilo está opcionalmente sustituido con uno o más halógenos, y en el que arilo está opcionalmente sustituido con uno o más grupos halógeno, (C1-C6)alquilo o NO2",GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/095-924-814-084-802,Granted Patent,no,0,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,0,0,,,,ACTIVE
85,AU,B2,AU 2012/255029 B2,107-127-085-369-665,2016-04-28,2016,AU 2012/255029 A,2012-05-18,US 201161488133 P;;US 2012/0038615 W,2011-05-19,Processes and intermediates for preparing anti-HIV agents,The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/107-127-085-369-665,Granted Patent,no,3,0,39,39,0,C07D473/34;;C07F9/4075;;C07F9/4449;;C07H19/16;;C07H19/02;;C07H19/04;;C07H19/173;;A61K31/66;;C07F9/65616;;C07H19/20;;C07H23/00;;C07H19/02;;C07H19/04;;C07H19/173;;A61K31/66;;C07D473/34;;C07F9/4075;;C07F9/4449;;C07H19/16;;C07F9/65616;;C07H19/20;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,0,0,,,,ACTIVE
86,US,B2,US 8987437 B2,124-994-361-144-879,2015-03-24,2015,US 201213475569 A,2012-05-18,US 201213475569 A;;US 201161488133 P,2011-05-19,Processes and intermediates for preparing anti-HIV Agents,The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN;;GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,GILEAD SCIENCES INC (2012-06-15),https://lens.org/124-994-361-144-879,Granted Patent,yes,11,6,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07H19/00;;C07D473/34;;C07F9/40;;C07F9/44;;C07F9/6561;;C07H19/16;;C07H19/20;;C07H23/00,536/27.2;;536/18.5;;536/18.6;;536/25.3;;536/27.1;;536/27.13,11,9,065-794-795-000-894;;003-944-913-687-458;;028-107-122-272-132;;030-286-349-224-117;;009-712-645-664-860;;044-156-633-677-511;;051-227-489-933-144;;015-518-911-586-809;;137-274-061-088-365,10.1128/aac.01209-07;;pmc2224749;;18056281;;10.1021/ja00206a058;;10.1016/s0960-894x(01)00128-7;;11327587;;18164198;;10.1016/j.bmcl.2007.11.125;;20391198;;10.1080/15257771003597758;;11563079;;10.1081/ncn-100002338;;10.1021/jo00199a026;;15058965;;10.1021/jo035508+;;10.1016/s0957-4166(98)00331-0,"Ray et al. Antimicrobial Agents and Chemotherapy (2008), vol. 52, pp. 648-654.;;Avila et al., ""Phosphonium Ion Fragmentations Relevant to Organophosphonate Biodegradation"", J. Am. Chem. Soc., 111, 8969-8970 (1989).;;Ballatore et al., ""Synthesis and Evaluation of Novel Amidate Prodrugs of PMEA and PMPA"", Bioorganic & Medicinal Chemistry Letters, 11, 1053-1056 (2001).;;Boojamra et al., ""Synthesis and anti-HIV activity of GS-9148 (2'-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitor"", Bioorganic & Medicinal Chemistry Letters, 18, 1120-1123 (2008).;;Cen et al., ""Efficient Syntheses of Clofarabine and Gemcitabine from 2-Deoxyribonolactone"", Nucleosides, Nucleotides and Nucleic Acids, 29, 113-122 (2010).;;Chapman et al., ""Practical Synthesis, Separation, and Stereochemical Assignment of the PMPA Pro-Drug GS-7340"", Nucleosides, Nucleotides & Nucleic Acids, 20 (4-7), 621-628 (2001).;;Fry et al., ""Alkylations Using Methyltrialkoxyphosphonium Tetrafluoborate Salts. Synthetic and Mechanistic Aspects of Methyl, Ethyl, 2-Propyl, and 2-Octyl Group Transfers"", J. Org. Chem., 49, 4877-4880 (1984).;;Hersh et al., ""Synthesis and Structural Characterization of Trivalent Amino Acid Derived Chiral Phosphorus Compounds"", J. Org. Chem., 69, 2153-2163 (2004).;;Kielbasinski et al., ""Lipase-promoted kinetic resolution of racemic, P-chiral hydroxymethylphosphonates and phosphinates"", Tetrahedron: Asymmetry 9, 3283-3287 (1998).;;Patent Cooperation Treaty, International Searching Authority, Search Report and Written Opinion for PCT/US2012/038615, 16 pages, Jul. 20, 2012.;;New Zealand Office Action mailed on Aug. 20, 2014, for New Zealand Patent Application No. 618939, filed on May 18, 2012, two pages.",ACTIVE
87,EP,A1,EP 3199537 A1,186-342-569-871-800,2017-08-02,2017,EP 16204289 A,2012-05-18,US 201161488133 P;;EP 12725570 A;;US 2012/0038615 W,2011-05-19,PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS,The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.,GILEAD SCIENCES INC,YU RICHARD HUNG CHIU;;BROWN BRANDON HEATH;;POLNIASZEK RICHARD P;;GRAETZ BENJAMIN R;;SUJINO KEIKO;;TRAN DUONG DUC-PHI;;TRIMAN ALAN SCOTT;;KENT KENNETH M;;PFEIFFER STEVEN,,https://lens.org/186-342-569-871-800,Patent Application,yes,10,0,39,39,0,A61K31/66;;A61K31/66;;C07H19/20;;C07H19/20;;C07D473/34;;C07D473/34;;C07F9/4075;;C07F9/4075;;C07F9/4449;;C07F9/4449;;C07F9/65616;;C07F9/65616;;C07H19/02;;C07H19/02;;C07H19/04;;C07H19/04;;C07H19/16;;C07H19/16;;C07H19/173;;C07H19/173;;C07H23/00;;C07H23/00,C07F9/40;;C07F9/44;;C07H19/20,,5,4,009-712-645-664-860;;030-286-349-224-117;;025-533-852-354-159;;135-304-912-500-023,20391198;;10.1080/15257771003597758;;18164198;;10.1016/j.bmcl.2007.11.125;;10.1016/b978-0-12-040811-5.50011-1;;10.1021/jo00219a048,"YANA CEN ET AL: ""Efficient Syntheses of Clofarabine and Gemcitabine From 2-Deoxyribonolactone"", NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS, vol. 29, no. 2, 26 February 2010 (2010-02-26), pages 113 - 122, XP055030987, ISSN: 1525-7770, DOI: 10.1080/15257771003597758;;BOOJAMRA ET AL: ""Synthesis and anti-HIV activity of GS-9148 (2'-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitor"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 18, no. 3, 5 December 2007 (2007-12-05), pages 1120 - 1123, XP022475698, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2007.11.125;;T. W. GREENE: ""Protecting Groups In Organic Synthesis"", 1981, WILEY;;TANN, C.H, J. ORG. CHEM., vol. 50, 1985, pages 3644 - 3647;;REC. TRAC. CHIM PAYS-BAS, vol. 105, 1986, pages 528 - 537",ACTIVE
88,US,B1,US 11890105 B1,179-064-648-727-347,2024-02-06,2024,US 202217893632 A,2022-08-23,US 202217893632 A,2022-08-23,Compute system with psoriasis diagnostic mechanism and method of operation thereof,"A method of operation of a compute system includes: generating a skin segmentation including a non-skin region and a skin prediction based on a patient image; generating a body part segmentation based on the patient image; generating a cropped image based on the skin segmentation and the body part segmentation with the cropped image includes the non-skin region based on the skin prediction; generating a psoriasis segmentation based on the cropped image and the skin prediction; generating intermediate scores for erythema, induration, desquamation for the cropped image; and generating a full body PASI score based a psoriasis segmentation and the intermediate scores on the for displaying on a device to assist in diagnosis.",BELLETORUS CORP,NGUYEN TIEN DUNG;;GAZEAU LÉA MATHILDE;;GLOSS MATTHEW GREGORY;;HUSTACHE-MARMOU THOMAS;;MARIWALLA KAVITA;;MCANELLY EMILY KATHRYN;;MORBITZER MEGAN M;;NGUYEN DUONG THUY;;NGUYEN HOANG-PHUONG;;NGUYEN NGA THI THUY;;NGUYEN THANG DUC;;NGUYEN THI THU HANG;;PERLIS CLIFFORD;;SZAJNA CHRISTOPHER C;;WOLFE JONATHAN,BELLETORUS CORPORATION (2022-08-18),https://lens.org/179-064-648-727-347,Granted Patent,yes,5,0,1,1,0,A61B5/441;;G06T7/0012;;G06T2207/30088;;G16H30/40;;G06T2207/20132;;G06T7/10;;A61B2576/02,A61B5/00;;G06T7/00;;G06T7/10;;G16H30/40,,3,1,045-815-056-278-571,31594034;;10.1111/jdv.16002,"N. Meienberger, F. Anzengruber, L. Amruthalingam, R. Christen,3 T. Koller, J.T. Maul, M Pouly, V. Djamei, and A.A. Navarini, article called “Observer-Independent Assessment of Psoriasis-Affected Area Using Machine Learning”, DOI: 10.1111/jdv.16002, JEADV 2020, 34, pp. 1362-1368, @ 2019 European Academy of Dermatology and Venereology.;;Olaf Ronneberger, Philipp Fischer, and Thomas Brox, “U-Net: Convolutional Networks for Biomedical Image Segmentation”, Computer Science Department and BIOSS Centre for Biological Signalling Studies, University of Freiburg, Germany, arXiv: 1505.04597v1 [cs.CV], May 18, 2015, 8 pages.;;Mingxing Tan and Quoc V. Le, “EfficientNet: Rethinking Model Scaling for Convolutional Neural Networks”, arXiv:1905.11947v5 [cs.LG] Sep. 11, 2020, 11 pages.",ACTIVE
